| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | HSPG2 VLDLR FBLN7 FBLN5 SPTA1 CUBN ADAM8 LRP1B F7 LDLR SVEP1 ADGRL4 STAB1 SLIT2 EYS FBLN2 FBN1 FBN2 OIT3 SCUBE2 HMCN1 NCAN SLIT1 SLIT3 LRP1 LRP2 DLK2 MACF1 LTBP2 LTBP3 AGRN FBN3 NOTCH1 NOTCH2 NOTCH3 PADI3 | 1.06e-22 | 749 | 122 | 36 | GO:0005509 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | HSPG2 FBLN5 VTN CILP TFPI2 SSPOP ZP1 SLIT2 FBLN2 FBN1 FBN2 HMCN1 LTBP2 DMBT1 MUC5AC AGRN FBN3 | 1.87e-15 | 188 | 122 | 17 | GO:0005201 |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 1.90e-14 | 16 | 122 | 8 | GO:0005041 | |
| GeneOntologyMolecularFunction | cargo receptor activity | VLDLR VTN CUBN LRP1B ITGB2 LDLR STAB1 LRP1 LRP2 LRP6 DMBT1 SORL1 | 1.41e-13 | 85 | 122 | 12 | GO:0038024 |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 2.93e-13 | 21 | 122 | 8 | GO:0030228 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | FBLN7 VTN ADAMTS8 STAB1 SLIT2 FBN1 NCAN SLIT1 SLIT3 LTBP2 DMBT1 AGRN | 9.37e-08 | 268 | 122 | 12 | GO:0005539 |
| GeneOntologyMolecularFunction | integrin binding | FBLN5 VTN ADAM18 ADAMTS8 ITGAV ADAM8 ITGB2 SVEP1 SLC6A4 FBN1 | 1.22e-07 | 175 | 122 | 10 | GO:0005178 |
| GeneOntologyMolecularFunction | structural molecule activity | HSPG2 FBLN5 VTN CILP TFPI2 SPTA1 SSPOP ZP1 SLIT2 FBLN2 FBN1 FBN2 HMCN1 CRYGN MACF1 LTBP2 DMBT1 MUC5AC AGRN FBN3 | 4.49e-07 | 891 | 122 | 20 | GO:0005198 |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 6.32e-07 | 12 | 122 | 4 | GO:0030023 | |
| GeneOntologyMolecularFunction | sulfur compound binding | FBLN7 VTN ADAMTS8 SLIT2 FBN1 SLIT1 SLIT3 LRP1 LTBP2 DMBT1 TSR3 AGRN | 6.93e-07 | 323 | 122 | 12 | GO:1901681 |
| GeneOntologyMolecularFunction | heparan sulfate proteoglycan binding | 8.28e-07 | 29 | 122 | 5 | GO:0043395 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 1.27e-06 | 14 | 122 | 4 | GO:0097493 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 5.60e-06 | 73 | 122 | 6 | GO:0050840 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 1.47e-05 | 51 | 122 | 5 | GO:0043394 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 2.09e-05 | 27 | 122 | 4 | GO:0005044 | |
| GeneOntologyMolecularFunction | heparin binding | 2.39e-05 | 192 | 122 | 8 | GO:0008201 | |
| GeneOntologyMolecularFunction | Roundabout binding | 4.70e-05 | 12 | 122 | 3 | GO:0048495 | |
| GeneOntologyMolecularFunction | lipoprotein particle binding | 6.00e-05 | 35 | 122 | 4 | GO:0071813 | |
| GeneOntologyMolecularFunction | protein-lipid complex binding | 6.00e-05 | 35 | 122 | 4 | GO:0071814 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 9.52e-05 | 120 | 122 | 6 | GO:0004222 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle binding | 1.70e-04 | 18 | 122 | 3 | GO:0030169 | |
| GeneOntologyMolecularFunction | very-low-density lipoprotein particle receptor activity | 2.20e-04 | 4 | 122 | 2 | GO:0030229 | |
| GeneOntologyMolecularFunction | histone H3K36 dimethyltransferase activity | 2.20e-04 | 4 | 122 | 2 | GO:0140954 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 2.35e-04 | 20 | 122 | 3 | GO:0034185 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | FBLN5 VTN ADAM18 ADAMTS8 ITGAV ADAM8 ITGB2 SVEP1 SLC6A4 FBN1 MACF1 NOTCH3 | 3.07e-04 | 599 | 122 | 12 | GO:0050839 |
| GeneOntologyMolecularFunction | regulatory region RNA binding | 3.66e-04 | 5 | 122 | 2 | GO:0001069 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 4.07e-04 | 102 | 122 | 5 | GO:0001540 | |
| GeneOntologyMolecularFunction | transforming growth factor beta binding | 5.22e-04 | 26 | 122 | 3 | GO:0050431 | |
| GeneOntologyMolecularFunction | protease binding | 8.66e-04 | 181 | 122 | 6 | GO:0002020 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 1.31e-03 | 430 | 122 | 9 | GO:0004175 | |
| GeneOntologyMolecularFunction | enzyme inhibitor activity | 1.42e-03 | 435 | 122 | 9 | GO:0004857 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 1.45e-03 | 200 | 122 | 6 | GO:0008237 | |
| GeneOntologyMolecularFunction | histone H4K20 methyltransferase activity | 1.61e-03 | 10 | 122 | 2 | GO:0042799 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor binding | 1.73e-03 | 39 | 122 | 3 | GO:0070325 | |
| GeneOntologyMolecularFunction | hemoglobin binding | 1.96e-03 | 11 | 122 | 2 | GO:0030492 | |
| GeneOntologyMolecularFunction | clathrin heavy chain binding | 2.35e-03 | 12 | 122 | 2 | GO:0032050 | |
| GeneOntologyMolecularFunction | growth factor binding | 2.72e-03 | 156 | 122 | 5 | GO:0019838 | |
| GeneOntologyMolecularFunction | insulin-like growth factor I binding | 2.76e-03 | 13 | 122 | 2 | GO:0031994 | |
| GeneOntologyMolecularFunction | histone H3K36 methyltransferase activity | 2.76e-03 | 13 | 122 | 2 | GO:0046975 | |
| GeneOntologyMolecularFunction | molecular function inhibitor activity | 3.60e-03 | 596 | 122 | 10 | GO:0140678 | |
| GeneOntologyMolecularFunction | histone H4 methyltransferase activity | 4.74e-03 | 17 | 122 | 2 | GO:0140939 | |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | 5.86e-03 | 187 | 122 | 5 | GO:0030414 | |
| GeneOntologyMolecularFunction | insulin-like growth factor binding | 5.92e-03 | 19 | 122 | 2 | GO:0005520 | |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis | HSPG2 VLDLR VTN CUBN ITGAV LRP1B ITGB2 LDLR STAB1 PROM2 LRP1 LRP2 LRP3 LRP6 DMBT1 SORL1 | 1.76e-10 | 337 | 123 | 16 | GO:0006898 |
| GeneOntologyBiologicalProcess | cardiac septum development | 1.11e-07 | 134 | 123 | 9 | GO:0003279 | |
| GeneOntologyBiologicalProcess | chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration | 2.07e-07 | 3 | 123 | 3 | GO:0021834 | |
| GeneOntologyBiologicalProcess | complement activation, classical pathway | 2.33e-07 | 44 | 123 | 6 | GO:0006958 | |
| GeneOntologyBiologicalProcess | vasculature development | VEGFC HSPG2 FBLN5 PLXDC1 ADGRB1 ADGRB3 ITGAV ADAM8 ITGB2 LDLR SVEP1 STAB1 SLIT2 TIE1 LRP1 LRP2 C6 CPLANE1 NOTCH1 NOTCH2 NOTCH3 | 2.69e-07 | 969 | 123 | 21 | GO:0001944 |
| GeneOntologyBiologicalProcess | circulatory system development | AKAP6 VEGFC HSPG2 FBLN5 PLXDC1 NSD2 ADGRB1 ADGRB3 ITGAV ADAM8 ITGB2 LDLR SVEP1 STAB1 SLIT2 FBN1 TIE1 SLIT3 LRP1 LRP2 LRP6 C6 CPLANE1 NOTCH1 NOTCH2 NOTCH3 | 3.07e-07 | 1442 | 123 | 26 | GO:0072359 |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | VEGFC HSPG2 FBLN5 PLXDC1 ADGRB1 ADGRB3 ITGAV ADAM8 ITGB2 LDLR STAB1 SLIT2 TIE1 LRP1 LRP2 C6 NOTCH1 NOTCH2 NOTCH3 | 3.71e-07 | 817 | 123 | 19 | GO:0048514 |
| GeneOntologyBiologicalProcess | blood vessel development | VEGFC HSPG2 FBLN5 PLXDC1 ADGRB1 ADGRB3 ITGAV ADAM8 ITGB2 LDLR STAB1 SLIT2 TIE1 LRP1 LRP2 C6 CPLANE1 NOTCH1 NOTCH2 NOTCH3 | 5.97e-07 | 929 | 123 | 20 | GO:0001568 |
| GeneOntologyBiologicalProcess | negative regulation of developmental process | VEGFC HSPG2 ZNF536 FBLN5 ADGRB1 ADGRB3 ITGAV LDLR STAB1 SLC6A4 SLIT2 FBN1 TIE1 STC2 SLIT1 LRP3 LRP6 LTBP3 LDLRAD4 NOTCH1 MBNL3 NOTCH3 SORL1 | 7.81e-07 | 1220 | 123 | 23 | GO:0051093 |
| GeneOntologyBiologicalProcess | regulation of nervous system development | VEGFC ADGRB1 ADGRB3 DCT LDLR SLIT2 NCAN SLIT1 LRP1 LRP2 LRP6 MACF1 AGRN NOTCH1 NOTCH2 SORL1 | 9.79e-07 | 625 | 123 | 16 | GO:0051960 |
| GeneOntologyBiologicalProcess | cardiac septum morphogenesis | 1.04e-06 | 89 | 123 | 7 | GO:0060411 | |
| GeneOntologyBiologicalProcess | ventricular septum development | 1.21e-06 | 91 | 123 | 7 | GO:0003281 | |
| GeneOntologyBiologicalProcess | humoral immune response mediated by circulating immunoglobulin | 1.86e-06 | 62 | 123 | 6 | GO:0002455 | |
| GeneOntologyBiologicalProcess | embryonic olfactory bulb interneuron precursor migration | 2.05e-06 | 5 | 123 | 3 | GO:0021831 | |
| GeneOntologyBiologicalProcess | positive regulation of lysosomal protein catabolic process | 2.05e-06 | 5 | 123 | 3 | GO:1905167 | |
| GeneOntologyBiologicalProcess | chemotaxis | VEGFC DOCK4 ITGAV ADAM8 ITGB2 F7 SLIT2 SLIT1 SLIT3 LRP1 LRP2 PLAUR AGRN NOTCH1 | 2.57e-06 | 517 | 123 | 14 | GO:0006935 |
| GeneOntologyBiologicalProcess | taxis | VEGFC DOCK4 ITGAV ADAM8 ITGB2 F7 SLIT2 SLIT1 SLIT3 LRP1 LRP2 PLAUR AGRN NOTCH1 | 2.69e-06 | 519 | 123 | 14 | GO:0042330 |
| GeneOntologyBiologicalProcess | extracellular matrix organization | HSPG2 FBLN5 VTN ADAMTS8 ADAM8 HMCN1 TIE1 LRP1 ADAMTS20 RXFP1 PBXIP1 NOTCH1 | 2.72e-06 | 377 | 123 | 12 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | HSPG2 FBLN5 VTN ADAMTS8 ADAM8 HMCN1 TIE1 LRP1 ADAMTS20 RXFP1 PBXIP1 NOTCH1 | 2.79e-06 | 378 | 123 | 12 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | HSPG2 FBLN5 VTN ADAMTS8 ADAM8 HMCN1 TIE1 LRP1 ADAMTS20 RXFP1 PBXIP1 NOTCH1 | 2.87e-06 | 379 | 123 | 12 | GO:0045229 |
| GeneOntologyBiologicalProcess | complement activation | 3.82e-06 | 70 | 123 | 6 | GO:0006956 | |
| GeneOntologyBiologicalProcess | angiogenesis | VEGFC HSPG2 FBLN5 PLXDC1 ADGRB1 ADGRB3 ITGAV ADAM8 ITGB2 STAB1 SLIT2 TIE1 C6 NOTCH1 NOTCH2 NOTCH3 | 4.87e-06 | 708 | 123 | 16 | GO:0001525 |
| GeneOntologyBiologicalProcess | cardiac chamber development | 5.17e-06 | 212 | 123 | 9 | GO:0003205 | |
| GeneOntologyBiologicalProcess | positive regulation of neuroblast proliferation | 6.27e-06 | 44 | 123 | 5 | GO:0002052 | |
| GeneOntologyBiologicalProcess | negative regulation of multicellular organismal process | DOCK4 HSPG2 FBLN5 VTN ADGRB1 ADGRB3 LDLR SVEP1 TFPI STAB1 SLC6A4 SLIT2 FBN1 TIE1 BRCA2 STC2 SLIT1 LRP6 PLAUR LTBP3 PLCL1 LDLRAD4 NOTCH1 SORL1 | 6.61e-06 | 1488 | 123 | 24 | GO:0051241 |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | VEGFC VTN CILP SLIT2 FBN1 FBN2 LRP1 LRP2 LDLRAD4 NOTCH1 NOTCH2 SORL1 | 6.72e-06 | 412 | 123 | 12 | GO:0090287 |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process in the vacuole | 7.12e-06 | 7 | 123 | 3 | GO:1904352 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | VEGFC ADGRB1 ADGRB3 DCT SLIT2 NCAN LRP1 LRP2 MACF1 AGRN NOTCH1 NOTCH2 | 7.77e-06 | 418 | 123 | 12 | GO:0051962 |
| GeneOntologyBiologicalProcess | tube development | VEGFC HSPG2 FBLN5 PLXDC1 ADGRB1 ADGRB3 ITGAV ADAM8 ITGB2 LDLR STAB1 SLIT2 FBN1 TIE1 LRP1 LRP2 LRP6 LTBP3 RXFP1 C6 NOTCH1 NOTCH2 NOTCH3 | 8.08e-06 | 1402 | 123 | 23 | GO:0035295 |
| GeneOntologyBiologicalProcess | axon guidance | 8.23e-06 | 285 | 123 | 10 | GO:0007411 | |
| GeneOntologyBiologicalProcess | positive regulation of neural precursor cell proliferation | 8.34e-06 | 80 | 123 | 6 | GO:2000179 | |
| GeneOntologyBiologicalProcess | endocytosis | HSPG2 VLDLR VTN ADGRB1 CUBN ITGAV LRP1B ITGB2 LDLR STAB1 PROM2 LRP1 LRP2 LRP3 LRP6 DMBT1 SORL1 | 8.41e-06 | 827 | 123 | 17 | GO:0006897 |
| GeneOntologyBiologicalProcess | neuron projection guidance | 8.49e-06 | 286 | 123 | 10 | GO:0097485 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | VEGFC HSPG2 FBLN5 PLXDC1 ADGRB1 ADGRB3 ITGAV ADAM8 ITGB2 LDLR STAB1 SLIT2 TIE1 LRP1 LRP2 LRP6 C6 NOTCH1 NOTCH2 NOTCH3 | 1.08e-05 | 1125 | 123 | 20 | GO:0035239 |
| GeneOntologyBiologicalProcess | semi-lunar valve development | 1.19e-05 | 50 | 123 | 5 | GO:1905314 | |
| GeneOntologyBiologicalProcess | regulation of neural precursor cell proliferation | 1.66e-05 | 135 | 123 | 7 | GO:2000177 | |
| GeneOntologyBiologicalProcess | ventricular septum morphogenesis | 2.08e-05 | 56 | 123 | 5 | GO:0060412 | |
| GeneOntologyBiologicalProcess | tangential migration from the subventricular zone to the olfactory bulb | 2.41e-05 | 10 | 123 | 3 | GO:0022028 | |
| GeneOntologyBiologicalProcess | olfactory bulb interneuron development | 3.30e-05 | 11 | 123 | 3 | GO:0021891 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | FBLN5 VTN TMEM8B ITGAV ADAM8 ITGB2 SVEP1 FBLN2 LRP1 MACF1 NOTCH1 | 3.52e-05 | 410 | 123 | 11 | GO:0031589 |
| GeneOntologyBiologicalProcess | endocytic hemoglobin import into cell | 3.53e-05 | 2 | 123 | 2 | GO:0020028 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 3.54e-05 | 270 | 123 | 9 | GO:0007160 | |
| GeneOntologyBiologicalProcess | heart valve morphogenesis | 3.70e-05 | 63 | 123 | 5 | GO:0003179 | |
| GeneOntologyBiologicalProcess | neuroblast proliferation | 3.75e-05 | 104 | 123 | 6 | GO:0007405 | |
| GeneOntologyBiologicalProcess | regulation of lysosomal protein catabolic process | 4.38e-05 | 12 | 123 | 3 | GO:1905165 | |
| GeneOntologyBiologicalProcess | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 4.98e-05 | 218 | 123 | 8 | GO:0090101 | |
| GeneOntologyBiologicalProcess | regulation of neuroblast proliferation | 4.99e-05 | 67 | 123 | 5 | GO:1902692 | |
| GeneOntologyBiologicalProcess | cardiac chamber morphogenesis | 5.16e-05 | 161 | 123 | 7 | GO:0003206 | |
| GeneOntologyBiologicalProcess | cardiac ventricle development | 5.16e-05 | 161 | 123 | 7 | GO:0003231 | |
| GeneOntologyBiologicalProcess | substrate-independent telencephalic tangential migration | 5.67e-05 | 13 | 123 | 3 | GO:0021826 | |
| GeneOntologyBiologicalProcess | substrate-independent telencephalic tangential interneuron migration | 5.67e-05 | 13 | 123 | 3 | GO:0021843 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | VEGFC DCT LDLR SLIT2 NCAN SLIT1 LRP1 LRP2 MACF1 NOTCH1 NOTCH2 SORL1 | 6.03e-05 | 515 | 123 | 12 | GO:0050767 |
| GeneOntologyBiologicalProcess | negative regulation of cell differentiation | VEGFC ZNF536 ITGAV LDLR SLC6A4 SLIT2 FBN1 SLIT1 LRP3 LRP6 LTBP3 LDLRAD4 NOTCH1 MBNL3 NOTCH3 SORL1 | 6.48e-05 | 875 | 123 | 16 | GO:0045596 |
| GeneOntologyBiologicalProcess | import into cell | HSPG2 VLDLR VTN ADGRB1 CUBN ITGAV LRP1B ITGB2 LDLR STAB1 SLC6A4 PROM2 LRP1 LRP2 LRP3 LRP6 DMBT1 SORL1 | 6.75e-05 | 1074 | 123 | 18 | GO:0098657 |
| GeneOntologyBiologicalProcess | regulation of protein catabolic process in the vacuole | 7.18e-05 | 14 | 123 | 3 | GO:1904350 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | CILP FBN1 FBN2 LRP1 LRP2 LTBP2 LTBP3 LDLRAD4 NOTCH1 NOTCH2 SORL1 | 7.35e-05 | 445 | 123 | 11 | GO:0141091 |
| GeneOntologyBiologicalProcess | neural precursor cell proliferation | 7.94e-05 | 233 | 123 | 8 | GO:0061351 | |
| GeneOntologyBiologicalProcess | aortic valve morphogenesis | 8.43e-05 | 39 | 123 | 4 | GO:0003180 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance | 9.32e-05 | 40 | 123 | 4 | GO:0097242 | |
| GeneOntologyBiologicalProcess | heart valve development | 1.04e-04 | 78 | 123 | 5 | GO:0003170 | |
| GeneOntologyBiologicalProcess | developmental growth | AKAP6 FBLN5 SLC6A4 SLIT2 EYS BRCA2 STC2 SLIT1 SLIT3 LRP1 LRP6 MACF1 DMBT1 AGRN NOTCH1 NOTCH2 | 1.04e-04 | 911 | 123 | 16 | GO:0048589 |
| GeneOntologyBiologicalProcess | cellular response to tumor cell | 1.05e-04 | 3 | 123 | 2 | GO:0071228 | |
| GeneOntologyBiologicalProcess | cholesterol import | 1.09e-04 | 16 | 123 | 3 | GO:0070508 | |
| GeneOntologyBiologicalProcess | humoral immune response | 1.33e-04 | 321 | 123 | 9 | GO:0006959 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | AKAP6 VEGFC ADAM8 DCT SLIT2 FBN2 SCUBE2 DPF3 NCAN LRP1 LRP2 LRP3 ADAMTS20 MACF1 LTBP3 DMBT1 NOTCH1 NOTCH2 | 1.45e-04 | 1141 | 123 | 18 | GO:0045597 |
| GeneOntologyBiologicalProcess | axonogenesis | HSPG2 ADGRB1 SLIT2 SLIT1 SLIT3 LRP1 LRP2 MACF1 AGRN NOTCH1 NOTCH2 NOTCH3 | 1.47e-04 | 566 | 123 | 12 | GO:0007409 |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | CILP FBN1 FBN2 LRP1 LRP2 LTBP2 LTBP3 LDLRAD4 NOTCH1 NOTCH2 SORL1 | 1.48e-04 | 482 | 123 | 11 | GO:0007178 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | HSPG2 VLDLR ADGRB1 ADGRB3 SLIT2 SLIT1 SLIT3 LRP1 LRP2 MACF1 AGRN NOTCH1 NOTCH2 NOTCH3 | 1.51e-04 | 748 | 123 | 14 | GO:0048667 |
| GeneOntologyBiologicalProcess | positive regulation of protein binding | 1.56e-04 | 85 | 123 | 5 | GO:0032092 | |
| GeneOntologyBiologicalProcess | aortic valve development | 1.62e-04 | 46 | 123 | 4 | GO:0003176 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | VEGFC HSPG2 FBLN5 VTN PLXDC1 ADGRB1 ADGRB3 ITGAV ADAM8 ITGB2 STAB1 SLIT2 FBN2 TIE1 LRP2 LRP6 MACF1 C6 NOTCH1 NOTCH2 NOTCH3 | 1.75e-04 | 1483 | 123 | 21 | GO:0048646 |
| GeneOntologyBiologicalProcess | complement activation, alternative pathway | 1.87e-04 | 19 | 123 | 3 | GO:0006957 | |
| GeneOntologyBiologicalProcess | bone development | 1.88e-04 | 264 | 123 | 8 | GO:0060348 | |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 2.10e-04 | 4 | 123 | 2 | GO:0035583 | |
| GeneOntologyBiologicalProcess | dorsal/ventral axon guidance | 2.10e-04 | 4 | 123 | 2 | GO:0033563 | |
| GeneOntologyBiologicalProcess | connective tissue development | 2.19e-04 | 343 | 123 | 9 | GO:0061448 | |
| GeneOntologyBiologicalProcess | pulmonary valve morphogenesis | 2.19e-04 | 20 | 123 | 3 | GO:0003184 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 2.26e-04 | 92 | 123 | 5 | GO:0048844 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | VEGFC VTN CILP F7 SVEP1 FBN1 FBN2 TIE1 LRP1 LRP2 PLAUR LTBP2 LTBP3 AGRN LDLRAD4 NOTCH1 NOTCH2 SORL1 | 2.33e-04 | 1186 | 123 | 18 | GO:0007167 |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 2.38e-04 | 347 | 123 | 9 | GO:0090092 | |
| GeneOntologyBiologicalProcess | negative chemotaxis | 2.42e-04 | 51 | 123 | 4 | GO:0050919 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | HSPG2 VLDLR SPTA1 ADGRB1 ADGRB3 ADAM8 ITGB2 SLIT2 SLIT1 SLIT3 LRP1 LRP2 LRP6 MACF1 AGRN NOTCH1 NOTCH2 NOTCH3 | 2.53e-04 | 1194 | 123 | 18 | GO:0000902 |
| GeneOntologyBiologicalProcess | central nervous system development | HSPG2 VLDLR VTN PLXDC1 DCT LDLR SLC6A4 SLIT2 BRCA2 NCAN SLIT1 SLIT3 LRP1 LRP2 LRP6 CPLANE1 NOTCH1 NOTCH3 | 2.61e-04 | 1197 | 123 | 18 | GO:0007417 |
| GeneOntologyBiologicalProcess | embryonic limb morphogenesis | 2.63e-04 | 148 | 123 | 6 | GO:0030326 | |
| GeneOntologyBiologicalProcess | embryonic appendage morphogenesis | 2.63e-04 | 148 | 123 | 6 | GO:0035113 | |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | 2.76e-04 | 354 | 123 | 9 | GO:0050769 | |
| GeneOntologyBiologicalProcess | axon extension involved in axon guidance | 2.93e-04 | 22 | 123 | 3 | GO:0048846 | |
| GeneOntologyBiologicalProcess | neuron projection extension involved in neuron projection guidance | 2.93e-04 | 22 | 123 | 3 | GO:1902284 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | HSPG2 VLDLR ADGRB1 ADGRB3 SLIT2 SLIT1 SLIT3 LRP1 LRP2 MACF1 AGRN NOTCH1 NOTCH2 NOTCH3 | 3.07e-04 | 802 | 123 | 14 | GO:0048812 |
| GeneOntologyBiologicalProcess | skeletal system development | HSPG2 FBLN5 NSD2 ARID5A FBN1 FBN2 SCUBE2 NCAN LRP6 LTBP3 PBXIP1 NOTCH2 | 3.14e-04 | 615 | 123 | 12 | GO:0001501 |
| GeneOntologyBiologicalProcess | embryo development | VEGFC HSPG2 VTN MBNL1 NSD1 CUBN ITGAV LRP1B SLIT2 FBN2 TIE1 BRCA2 LRP2 LRP6 MACF1 C6 DMBT1 CPLANE1 NOTCH1 NOTCH2 | 3.19e-04 | 1437 | 123 | 20 | GO:0009790 |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | VEGFC HSPG2 VTN MBNL1 NSD1 ITGAV FBN2 LRP2 LRP6 MACF1 CPLANE1 NOTCH1 NOTCH2 | 3.37e-04 | 713 | 123 | 13 | GO:0048598 |
| GeneOntologyBiologicalProcess | chemoattraction of axon | 3.49e-04 | 5 | 123 | 2 | GO:0061642 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | HSPG2 VLDLR ADGRB1 ADGRB3 SLIT2 SLIT1 SLIT3 LRP1 LRP2 MACF1 AGRN NOTCH1 NOTCH2 NOTCH3 | 3.79e-04 | 819 | 123 | 14 | GO:0120039 |
| GeneOntologyBiologicalProcess | pulmonary valve development | 3.82e-04 | 24 | 123 | 3 | GO:0003177 | |
| GeneOntologyBiologicalProcess | lysosomal protein catabolic process | 3.82e-04 | 24 | 123 | 3 | GO:1905146 | |
| GeneOntologyBiologicalProcess | lymph vessel morphogenesis | 3.82e-04 | 24 | 123 | 3 | GO:0036303 | |
| GeneOntologyBiologicalProcess | positive regulation of immune system process | VEGFC NSD2 SPTA1 RNF185 ALPK1 CFI ADAM8 ITGB2 F7 ARID5A SVEP1 DHX9 LACC1 C6 C8A C8B C9 NOTCH2 | 4.07e-04 | 1242 | 123 | 18 | GO:0002684 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | HSPG2 VLDLR ADGRB1 ADGRB3 SLIT2 SLIT1 SLIT3 LRP1 LRP2 MACF1 AGRN NOTCH1 NOTCH2 NOTCH3 | 4.13e-04 | 826 | 123 | 14 | GO:0048858 |
| GeneOntologyBiologicalProcess | axon development | HSPG2 ADGRB1 SLIT2 SLIT1 SLIT3 LRP1 LRP2 MACF1 AGRN NOTCH1 NOTCH2 NOTCH3 | 4.62e-04 | 642 | 123 | 12 | GO:0061564 |
| GeneOntologyCellularComponent | extracellular matrix | HSPG2 FBLN7 FBLN5 VTN CILP TFPI2 MUC5B ADAMTS8 SSPOP F7 SVEP1 ZP1 SLIT2 EYS FBLN2 FBN1 FBN2 HMCN1 NCAN ADAMTS20 LTBP2 LTBP3 DMBT1 PZP MUC5AC AGRN FBN3 | 8.10e-16 | 656 | 122 | 27 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | HSPG2 FBLN7 FBLN5 VTN CILP TFPI2 MUC5B ADAMTS8 SSPOP F7 SVEP1 ZP1 SLIT2 EYS FBLN2 FBN1 FBN2 HMCN1 NCAN ADAMTS20 LTBP2 LTBP3 DMBT1 PZP MUC5AC AGRN FBN3 | 8.73e-16 | 658 | 122 | 27 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | HSPG2 FBLN5 VTN CILP ADAMTS8 SSPOP F7 ZP1 SLIT2 EYS FBLN2 FBN1 FBN2 HMCN1 NCAN ADAMTS20 LTBP2 LTBP3 DMBT1 PZP AGRN | 3.93e-12 | 530 | 122 | 21 | GO:0062023 |
| GeneOntologyCellularComponent | membrane attack complex | 3.81e-08 | 7 | 122 | 4 | GO:0005579 | |
| GeneOntologyCellularComponent | cell surface | VLDLR TMEM8B ADAM21 CUBN ITGAV ADAM8 ITGB2 LDLR TFPI SLIT2 SCUBE2 PROM2 LRP1 LRP2 LRP6 PLAUR AGRN NOTCH1 NOTCH2 NOTCH3 SORL1 | 1.72e-06 | 1111 | 122 | 21 | GO:0009986 |
| GeneOntologyCellularComponent | Golgi lumen | 3.53e-06 | 109 | 122 | 7 | GO:0005796 | |
| GeneOntologyCellularComponent | clathrin-coated pit | 7.38e-06 | 80 | 122 | 6 | GO:0005905 | |
| GeneOntologyCellularComponent | pore complex | 1.49e-05 | 26 | 122 | 4 | GO:0046930 | |
| GeneOntologyCellularComponent | receptor complex | VLDLR PLXDC1 CUBN ITGAV LRP1B ITGB2 LDLR TIE1 LRP1 LRP2 NOTCH1 NOTCH2 NOTCH3 | 3.56e-05 | 581 | 122 | 13 | GO:0043235 |
| GeneOntologyCellularComponent | microfibril | 5.31e-05 | 13 | 122 | 3 | GO:0001527 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | MGAM CUBN ITGAV ADAM8 DCT ITGB2 LDLR STAB1 SLC6A4 MALRD1 NPC1L1 LRP1 LRP2 LRP6 ANP32E PLAUR DMBT1 LDLRAD4 NOTCH1 SORL1 | 6.69e-05 | 1307 | 122 | 20 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | MGAM CUBN ITGAV ADAM8 DCT ITGB2 LDLR STAB1 SLC6A4 MALRD1 NPC1L1 LRP1 LRP2 LRP6 ANP32E PLAUR DMBT1 LDLRAD4 NOTCH1 SORL1 | 8.07e-05 | 1325 | 122 | 20 | GO:0012506 |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 3.92e-04 | 59 | 122 | 4 | GO:0098636 | |
| GeneOntologyCellularComponent | basement membrane | 7.50e-04 | 122 | 122 | 5 | GO:0005604 | |
| GeneOntologyCellularComponent | cell-substrate junction | 1.17e-03 | 443 | 122 | 9 | GO:0030055 | |
| GeneOntologyCellularComponent | microvillus membrane | 1.41e-03 | 38 | 122 | 3 | GO:0031528 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 1.54e-03 | 212 | 122 | 6 | GO:0030666 | |
| GeneOntologyCellularComponent | plasma membrane raft | 1.72e-03 | 147 | 122 | 5 | GO:0044853 | |
| GeneOntologyCellularComponent | endocytic vesicle | 1.88e-03 | 384 | 122 | 8 | GO:0030139 | |
| GeneOntologyCellularComponent | specific granule membrane | 2.00e-03 | 91 | 122 | 4 | GO:0035579 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 2.15e-03 | 785 | 122 | 12 | GO:0098797 | |
| GeneOntologyCellularComponent | axonal growth cone | 2.30e-03 | 45 | 122 | 3 | GO:0044295 | |
| GeneOntologyCellularComponent | lysosomal lumen | 2.61e-03 | 98 | 122 | 4 | GO:0043202 | |
| HumanPheno | Decreased circulating terminal complement component concentration | 7.18e-08 | 6 | 44 | 4 | HP:0033057 | |
| HumanPheno | Recurrent Neisserial infections | 2.05e-05 | 7 | 44 | 3 | HP:0005430 | |
| HumanPheno | Choroidal neovascularization | 3.81e-05 | 23 | 44 | 4 | HP:0011506 | |
| HumanPheno | Fifth metacarpal with ulnar notch | 7.29e-05 | 2 | 44 | 2 | HP:0005900 | |
| HumanPheno | Decreased circulating complement C8 concentration | 7.29e-05 | 2 | 44 | 2 | HP:0004434 | |
| HumanPheno | Abnormal morphology of the choroidal vasculature | 8.53e-05 | 28 | 44 | 4 | HP:0025568 | |
| HumanPheno | Abnormal mitral valve physiology | 1.24e-04 | 180 | 44 | 8 | HP:0031481 | |
| HumanPheno | Reduced circulating complement concentration | 1.24e-04 | 58 | 44 | 5 | HP:0004431 | |
| HumanPheno | Abnormality of complement system | 1.58e-04 | 61 | 44 | 5 | HP:0005339 | |
| Domain | EGF_3 | HSPG2 VLDLR FBLN7 FBLN5 TMEM8B ADAM21 ADAM18 ADAM32 CUBN ADAM8 SSPOP LRP1B F7 LDLR SVEP1 ADGRL4 STAB1 SLIT2 EYS FBLN2 FBN1 FBN2 OIT3 MALRD1 SCUBE2 HMCN1 TIE1 NCAN SLIT1 SLIT3 LRP1 LRP2 DLK2 LRP6 LTBP2 LTBP3 C6 C8A C8B C9 AGRN FBN3 NOTCH1 NOTCH2 NOTCH3 SORL1 | 1.63e-56 | 235 | 122 | 46 | PS50026 |
| Domain | EGF_2 | HSPG2 VLDLR FBLN7 FBLN5 TMEM8B ADAM21 ADAM18 ADAM32 CUBN ADAM8 SSPOP LRP1B ITGB2 F7 LDLR SVEP1 ADGRL4 STAB1 SLIT2 EYS FBLN2 FBN1 FBN2 OIT3 MALRD1 SCUBE2 HMCN1 TIE1 NCAN SLIT1 SLIT3 LRP1 LRP2 DLK2 LRP6 LTBP2 LTBP3 C6 C8A C8B C9 AGRN FBN3 NOTCH1 NOTCH2 NOTCH3 SORL1 | 1.24e-55 | 265 | 122 | 47 | PS01186 |
| Domain | EGF_1 | HSPG2 VLDLR FBLN7 FBLN5 TMEM8B ADAM21 ADAM18 ADAM32 CUBN ADAM8 SSPOP LRP1B ITGB2 F7 LDLR SVEP1 STAB1 SLIT2 EYS FBLN2 FBN1 FBN2 OIT3 MALRD1 SCUBE2 HMCN1 TIE1 NCAN SLIT1 SLIT3 LRP1 LRP2 DLK2 LRP6 LTBP2 LTBP3 C6 C8A C8B C9 AGRN FBN3 NOTCH1 NOTCH2 NOTCH3 | 4.99e-53 | 255 | 122 | 45 | PS00022 |
| Domain | EGF-like_CS | HSPG2 VLDLR FBLN7 FBLN5 TMEM8B ADAM21 ADAM18 ADAM32 CUBN ADAM8 LRP1B ITGB2 F7 LDLR SVEP1 ADGRL4 STAB1 SLIT2 EYS FBLN2 FBN1 FBN2 MALRD1 SCUBE2 HMCN1 TIE1 NCAN SLIT1 SLIT3 LRP1 LRP2 DLK2 LRP6 LTBP2 LTBP3 C6 C8A C8B C9 AGRN FBN3 NOTCH1 NOTCH2 NOTCH3 SORL1 | 1.53e-52 | 261 | 122 | 45 | IPR013032 |
| Domain | EGF-like_dom | HSPG2 VLDLR FBLN7 FBLN5 ADAM21 ADAM18 ADAM32 CUBN ADAM8 LRP1B F7 LDLR SVEP1 ADGRL4 STAB1 SLIT2 EYS FBLN2 FBN1 FBN2 OIT3 MALRD1 SCUBE2 HMCN1 TIE1 NCAN SLIT1 SLIT3 LRP1 LRP2 DLK2 LRP6 LTBP2 LTBP3 C6 C8A C8B C9 AGRN FBN3 NOTCH1 NOTCH2 NOTCH3 SORL1 | 8.14e-52 | 249 | 122 | 44 | IPR000742 |
| Domain | EGF | HSPG2 VLDLR FBLN7 FBLN5 TMEM8B ADAM32 CUBN ADAM8 LRP1B F7 LDLR SVEP1 ADGRL4 STAB1 SLIT2 EYS FBLN2 FBN1 FBN2 OIT3 MALRD1 SCUBE2 HMCN1 TIE1 NCAN SLIT1 SLIT3 LRP1 LRP2 DLK2 LRP6 LTBP2 LTBP3 AGRN FBN3 NOTCH1 NOTCH2 NOTCH3 SORL1 | 1.49e-44 | 235 | 122 | 39 | SM00181 |
| Domain | EGF_CA | HSPG2 VLDLR FBLN7 FBLN5 CUBN LRP1B F7 LDLR SVEP1 ADGRL4 STAB1 SLIT2 EYS FBLN2 FBN1 FBN2 OIT3 SCUBE2 HMCN1 NCAN SLIT1 SLIT3 LRP1 LRP2 DLK2 LTBP2 LTBP3 AGRN FBN3 NOTCH1 NOTCH2 NOTCH3 | 2.35e-43 | 122 | 122 | 32 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | HSPG2 VLDLR FBLN7 FBLN5 CUBN LRP1B F7 LDLR SVEP1 ADGRL4 STAB1 SLIT2 EYS FBLN2 FBN1 FBN2 OIT3 SCUBE2 HMCN1 NCAN SLIT1 SLIT3 LRP1 LRP2 DLK2 LTBP2 LTBP3 AGRN FBN3 NOTCH1 NOTCH2 NOTCH3 | 4.24e-43 | 124 | 122 | 32 | IPR001881 |
| Domain | EGF_Ca-bd_CS | VLDLR FBLN7 FBLN5 CUBN LRP1B F7 LDLR SVEP1 ADGRL4 SLIT2 EYS FBLN2 FBN1 FBN2 OIT3 SCUBE2 HMCN1 NCAN SLIT1 SLIT3 LRP1 LRP2 DLK2 LTBP2 LTBP3 FBN3 NOTCH1 NOTCH2 NOTCH3 | 3.73e-41 | 97 | 122 | 29 | IPR018097 |
| Domain | EGF_CA | VLDLR FBLN7 FBLN5 CUBN LRP1B F7 LDLR SVEP1 ADGRL4 SLIT2 EYS FBLN2 FBN1 FBN2 OIT3 SCUBE2 HMCN1 NCAN SLIT1 SLIT3 LRP1 LRP2 DLK2 LTBP2 LTBP3 FBN3 NOTCH1 NOTCH2 NOTCH3 | 7.43e-41 | 99 | 122 | 29 | PS01187 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | VLDLR FBLN7 FBLN5 CUBN LRP1B F7 LDLR SVEP1 ADGRL4 SLIT2 EYS FBLN2 FBN1 FBN2 OIT3 SCUBE2 HMCN1 NCAN SLIT1 SLIT3 LRP1 LRP2 DLK2 LTBP2 LTBP3 FBN3 NOTCH1 NOTCH2 NOTCH3 | 7.27e-40 | 106 | 122 | 29 | IPR000152 |
| Domain | ASX_HYDROXYL | VLDLR FBLN7 FBLN5 CUBN LRP1B F7 LDLR SVEP1 ADGRL4 SLIT2 EYS FBLN2 FBN1 FBN2 OIT3 SCUBE2 HMCN1 NCAN LRP1 LRP2 DLK2 LTBP2 LTBP3 FBN3 NOTCH1 NOTCH2 NOTCH3 | 6.16e-37 | 100 | 122 | 27 | PS00010 |
| Domain | LDLR_class-A_CS | HSPG2 VLDLR CFI SSPOP LRP1B MAMDC4 LDLR MALRD1 LRP1 LRP2 LRP3 LRP6 RXFP1 C6 C8A C8B C9 TMPRSS7 LDLRAD4 SORL1 | 4.83e-34 | 40 | 122 | 20 | IPR023415 |
| Domain | EGF | HSPG2 VLDLR FBLN7 CUBN LRP1B F7 SVEP1 STAB1 SLIT2 EYS MALRD1 SCUBE2 HMCN1 TIE1 NCAN SLIT1 SLIT3 LRP1 LRP2 DLK2 LRP6 LTBP2 AGRN FBN3 NOTCH1 NOTCH2 NOTCH3 | 6.60e-34 | 126 | 122 | 27 | PF00008 |
| Domain | Ldl_recept_a | HSPG2 VLDLR CFI SSPOP LRP1B MAMDC4 LDLR MALRD1 LRP1 LRP2 LRP3 LRP6 RXFP1 C6 C8A C8B C9 TMPRSS7 LDLRAD4 SORL1 | 1.08e-32 | 45 | 122 | 20 | PF00057 |
| Domain | LDLRA_1 | HSPG2 VLDLR CFI SSPOP LRP1B MAMDC4 LDLR MALRD1 LRP1 LRP2 LRP3 LRP6 RXFP1 C6 C8A C8B C9 TMPRSS7 LDLRAD4 SORL1 | 5.62e-32 | 48 | 122 | 20 | PS01209 |
| Domain | LDrepeatLR_classA_rpt | HSPG2 VLDLR CFI SSPOP LRP1B MAMDC4 LDLR MALRD1 LRP1 LRP2 LRP3 LRP6 RXFP1 C6 C8A C8B C9 TMPRSS7 LDLRAD4 SORL1 | 9.45e-32 | 49 | 122 | 20 | IPR002172 |
| Domain | LDLa | HSPG2 VLDLR CFI SSPOP LRP1B MAMDC4 LDLR MALRD1 LRP1 LRP2 LRP3 LRP6 RXFP1 C6 C8A C8B C9 TMPRSS7 LDLRAD4 SORL1 | 9.45e-32 | 49 | 122 | 20 | SM00192 |
| Domain | LDLRA_2 | HSPG2 VLDLR CFI SSPOP LRP1B MAMDC4 LDLR MALRD1 LRP1 LRP2 LRP3 LRP6 RXFP1 C6 C8A C8B C9 TMPRSS7 LDLRAD4 SORL1 | 9.45e-32 | 49 | 122 | 20 | PS50068 |
| Domain | Growth_fac_rcpt_ | HSPG2 VLDLR FBLN5 CUBN LRP1B LDLR SVEP1 STAB1 EYS FBLN2 FBN1 FBN2 SCUBE2 HMCN1 TIE1 SLIT1 SLIT3 LRP1 LRP2 LTBP2 LTBP3 C8A C9 FBN3 NOTCH1 NOTCH2 NOTCH3 | 3.36e-31 | 156 | 122 | 27 | IPR009030 |
| Domain | - | HSPG2 VLDLR CFI SSPOP LRP1B MAMDC4 LDLR MALRD1 LRP1 LRP2 LRP3 LRP6 RXFP1 C8A C9 TMPRSS7 LDLRAD4 SORL1 | 3.07e-28 | 46 | 122 | 18 | 4.10.400.10 |
| Domain | EGF_CA | VLDLR FBLN7 FBLN5 CUBN LRP1B LDLR SVEP1 ADGRL4 FBLN2 FBN1 FBN2 SCUBE2 HMCN1 LRP1 LRP2 LTBP2 LTBP3 FBN3 NOTCH1 NOTCH2 NOTCH3 | 8.73e-28 | 86 | 122 | 21 | PF07645 |
| Domain | cEGF | FBLN5 LRP1B FBLN2 FBN1 FBN2 SCUBE2 HMCN1 LRP1 LRP2 LTBP3 FBN3 | 4.15e-18 | 26 | 122 | 11 | PF12662 |
| Domain | cEGF | FBLN5 LRP1B FBLN2 FBN1 FBN2 SCUBE2 HMCN1 LRP1 LRP2 LTBP3 FBN3 | 4.15e-18 | 26 | 122 | 11 | IPR026823 |
| Domain | hEGF | SVEP1 SLIT2 EYS FBN2 SLIT1 DLK2 LTBP3 FBN3 NOTCH1 NOTCH2 NOTCH3 | 1.14e-17 | 28 | 122 | 11 | PF12661 |
| Domain | EGF_extracell | ADAM18 ADAM32 ADAM8 LRP1B ITGB2 SVEP1 STAB1 TIE1 LRP2 DLK2 LTBP2 NOTCH1 NOTCH3 | 8.17e-17 | 60 | 122 | 13 | IPR013111 |
| Domain | EGF_2 | ADAM18 ADAM32 ADAM8 LRP1B ITGB2 SVEP1 STAB1 TIE1 LRP2 DLK2 LTBP2 NOTCH1 NOTCH3 | 8.17e-17 | 60 | 122 | 13 | PF07974 |
| Domain | TSP_1 | CILP ADGRB1 ADGRB3 ADAMTS8 SSPOP HMCN1 ADAMTS20 C6 C8A C8B C9 | 2.70e-13 | 63 | 122 | 11 | PF00090 |
| Domain | TSP1 | CILP ADGRB1 ADGRB3 ADAMTS8 SSPOP HMCN1 ADAMTS20 C6 C8A C8B C9 | 3.88e-13 | 65 | 122 | 11 | SM00209 |
| Domain | TSP1_rpt | CILP ADGRB1 ADGRB3 ADAMTS8 SSPOP HMCN1 ADAMTS20 C6 C8A C8B C9 | 3.88e-13 | 65 | 122 | 11 | IPR000884 |
| Domain | TSP1 | CILP ADGRB1 ADGRB3 ADAMTS8 SSPOP HMCN1 ADAMTS20 C6 C8A C8B C9 | 3.88e-13 | 65 | 122 | 11 | PS50092 |
| Domain | Ldl_recept_b | 1.41e-12 | 14 | 122 | 7 | PF00058 | |
| Domain | LDLRB | 1.41e-12 | 14 | 122 | 7 | PS51120 | |
| Domain | LY | 2.63e-12 | 15 | 122 | 7 | SM00135 | |
| Domain | LDLR_classB_rpt | 2.63e-12 | 15 | 122 | 7 | IPR000033 | |
| Domain | TB | 2.28e-10 | 7 | 122 | 5 | PF00683 | |
| Domain | - | 6.04e-10 | 8 | 122 | 5 | 3.90.290.10 | |
| Domain | CTCK_1 | 1.19e-09 | 18 | 122 | 6 | PS01185 | |
| Domain | TB_dom | 1.35e-09 | 9 | 122 | 5 | IPR017878 | |
| Domain | TB | 1.35e-09 | 9 | 122 | 5 | PS51364 | |
| Domain | - | 5.52e-09 | 39 | 122 | 7 | 2.120.10.30 | |
| Domain | Cys_knot_C | 1.10e-08 | 25 | 122 | 6 | IPR006207 | |
| Domain | CTCK_2 | 1.10e-08 | 25 | 122 | 6 | PS01225 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.85e-08 | 46 | 122 | 7 | IPR011042 | |
| Domain | MACPF_CS | 2.57e-08 | 6 | 122 | 4 | IPR020863 | |
| Domain | MACPF_2 | 5.97e-08 | 7 | 122 | 4 | PS51412 | |
| Domain | MACPF_1 | 5.97e-08 | 7 | 122 | 4 | PS00279 | |
| Domain | LAM_G_DOMAIN | 1.60e-07 | 38 | 122 | 6 | PS50025 | |
| Domain | Pep_M12B_propep | 1.88e-07 | 39 | 122 | 6 | PF01562 | |
| Domain | Peptidase_M12B_N | 1.88e-07 | 39 | 122 | 6 | IPR002870 | |
| Domain | DISINTEGRIN_1 | 2.20e-07 | 40 | 122 | 6 | PS00427 | |
| Domain | Reprolysin | 2.20e-07 | 40 | 122 | 6 | PF01421 | |
| Domain | ADAM_MEPRO | 2.20e-07 | 40 | 122 | 6 | PS50215 | |
| Domain | DISINTEGRIN_2 | 2.20e-07 | 40 | 122 | 6 | PS50214 | |
| Domain | Peptidase_M12B | 2.20e-07 | 40 | 122 | 6 | IPR001590 | |
| Domain | Disintegrin_dom | 2.56e-07 | 41 | 122 | 6 | IPR001762 | |
| Domain | CT | 2.64e-07 | 22 | 122 | 5 | SM00041 | |
| Domain | DUF3454 | 2.72e-07 | 3 | 122 | 3 | PF11936 | |
| Domain | DUF3454_notch | 2.72e-07 | 3 | 122 | 3 | IPR024600 | |
| Domain | DUF3454 | 2.72e-07 | 3 | 122 | 3 | SM01334 | |
| Domain | FBN | 2.72e-07 | 3 | 122 | 3 | IPR011398 | |
| Domain | MAC_perforin | 3.53e-07 | 10 | 122 | 4 | IPR001862 | |
| Domain | LamG | 3.96e-07 | 44 | 122 | 6 | SM00282 | |
| Domain | GFP-like | 5.52e-07 | 11 | 122 | 4 | IPR023413 | |
| Domain | MACPF | 5.52e-07 | 11 | 122 | 4 | PF01823 | |
| Domain | - | 5.52e-07 | 11 | 122 | 4 | 2.40.155.10 | |
| Domain | Laminin_G_1 | 5.52e-07 | 11 | 122 | 4 | PF00054 | |
| Domain | ADAM_Cys-rich | 7.88e-07 | 27 | 122 | 5 | IPR006586 | |
| Domain | ACR | 7.88e-07 | 27 | 122 | 5 | SM00608 | |
| Domain | MACPF | 8.24e-07 | 12 | 122 | 4 | IPR020864 | |
| Domain | MACPF | 8.24e-07 | 12 | 122 | 4 | SM00457 | |
| Domain | FacI_MAC | 1.08e-06 | 4 | 122 | 3 | IPR003884 | |
| Domain | Notch | 1.08e-06 | 4 | 122 | 3 | IPR008297 | |
| Domain | NODP | 1.08e-06 | 4 | 122 | 3 | PF07684 | |
| Domain | Notch_NODP_dom | 1.08e-06 | 4 | 122 | 3 | IPR011656 | |
| Domain | Notch_NOD_dom | 1.08e-06 | 4 | 122 | 3 | IPR010660 | |
| Domain | NOD | 1.08e-06 | 4 | 122 | 3 | PF06816 | |
| Domain | FIMAC | 1.08e-06 | 4 | 122 | 3 | SM00057 | |
| Domain | NOD | 1.08e-06 | 4 | 122 | 3 | SM01338 | |
| Domain | NODP | 1.08e-06 | 4 | 122 | 3 | SM01339 | |
| Domain | CUB | 1.23e-06 | 53 | 122 | 6 | PS01180 | |
| Domain | TIL_dom | 1.65e-06 | 14 | 122 | 4 | IPR002919 | |
| Domain | ConA-like_dom | HSPG2 HNRNPUL1 MAMDC4 SVEP1 SLIT2 EYS MALRD1 SLIT1 SLIT3 AGRN | 1.76e-06 | 219 | 122 | 10 | IPR013320 |
| Domain | CUB_dom | 1.90e-06 | 57 | 122 | 6 | IPR000859 | |
| Domain | Laminin_G | 2.11e-06 | 58 | 122 | 6 | IPR001791 | |
| Domain | LNR | 2.69e-06 | 5 | 122 | 3 | PS50258 | |
| Domain | - | 2.93e-06 | 95 | 122 | 7 | 2.60.120.200 | |
| Domain | Disintegrin_CS | 2.97e-06 | 16 | 122 | 4 | IPR018358 | |
| Domain | ADAM_CR | 4.94e-06 | 18 | 122 | 4 | PF08516 | |
| Domain | WxxW_domain | 5.36e-06 | 6 | 122 | 3 | IPR025155 | |
| Domain | Mucin2_WxxW | 5.36e-06 | 6 | 122 | 3 | PF13330 | |
| Domain | Laminin_G_2 | 6.00e-06 | 40 | 122 | 5 | PF02210 | |
| Domain | - | 7.74e-06 | 20 | 122 | 4 | 4.10.70.10 | |
| Domain | Notch_dom | 9.34e-06 | 7 | 122 | 3 | IPR000800 | |
| Domain | Notch | 9.34e-06 | 7 | 122 | 3 | PF00066 | |
| Domain | NL | 9.34e-06 | 7 | 122 | 3 | SM00004 | |
| Domain | Disintegrin | 9.52e-06 | 21 | 122 | 4 | PF00200 | |
| Domain | DISIN | 9.52e-06 | 21 | 122 | 4 | SM00050 | |
| Domain | - | 1.49e-05 | 81 | 122 | 6 | 3.40.390.10 | |
| Domain | MetalloPept_cat_dom | 1.49e-05 | 81 | 122 | 6 | IPR024079 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 2.76e-12 | 37 | 98 | 9 | M27134 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.51e-11 | 44 | 98 | 9 | M26969 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 3.74e-11 | 32 | 98 | 8 | MM14854 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 2.10e-10 | 39 | 98 | 8 | MM14601 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_MAC_INHIBITION | 1.81e-09 | 9 | 98 | 5 | M47881 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | HSPG2 FBLN5 VTN ADAMTS8 ITGAV ADAM8 ITGB2 FBLN2 FBN1 FBN2 NCAN LTBP2 LTBP3 AGRN FBN3 | 2.19e-09 | 300 | 98 | 15 | M610 |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | HSPG2 MUC5B ADAMTS8 SSPOP NCAN ADAMTS20 MUC5AC AGRN NOTCH1 NOTCH2 NOTCH3 | 4.19e-09 | 143 | 98 | 11 | M27275 |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 2.14e-08 | 68 | 98 | 8 | M27303 | |
| Pathway | KEGG_COMPLEMENT_AND_COAGULATION_CASCADES | 2.41e-08 | 69 | 98 | 8 | M16894 | |
| Pathway | KEGG_MEDICUS_REFERENCE_COMMON_PATHWAY_OF_COMPLEMENT_CASCADE_MAC_FORMATION | 7.56e-08 | 7 | 98 | 4 | M47873 | |
| Pathway | REACTOME_TERMINAL_PATHWAY_OF_COMPLEMENT | 1.50e-07 | 8 | 98 | 4 | MM14656 | |
| Pathway | REACTOME_TERMINAL_PATHWAY_OF_COMPLEMENT | 1.50e-07 | 8 | 98 | 4 | M27006 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | HSPG2 MUC5B ADAMTS8 CUBN SSPOP NCAN ADAMTS20 MUC5AC AGRN NOTCH1 NOTCH2 NOTCH3 | 1.57e-07 | 250 | 98 | 12 | M27554 |
| Pathway | WP_COMPLEMENT_SYSTEM | 3.28e-07 | 96 | 98 | 8 | M39581 | |
| Pathway | PID_UPA_UPAR_PATHWAY | 4.14e-07 | 42 | 98 | 6 | M174 | |
| Pathway | WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY | 7.04e-07 | 106 | 98 | 8 | M42535 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | FBLN5 VTN ITGAV ADAM8 ITGB2 FBLN2 FBN1 FBN2 LTBP2 LTBP3 AGRN | 1.71e-06 | 258 | 98 | 11 | MM14572 |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | VLDLR VTN CUBN CFI LRP1B LDLR NPC1L1 LRP1 LRP2 LRP3 LRP6 DMBT1 SORL1 | 2.25e-06 | 381 | 98 | 13 | M48063 |
| Pathway | WP_COMPLEMENT_AND_COAGULATION_CASCADES | 2.92e-06 | 58 | 98 | 6 | M39649 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 3.23e-06 | 5 | 98 | 3 | M27411 | |
| Pathway | WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES | 3.24e-06 | 59 | 98 | 6 | M48343 | |
| Pathway | KEGG_PRION_DISEASES | 4.03e-06 | 35 | 98 | 5 | M13036 | |
| Pathway | PID_INTEGRIN5_PATHWAY | 4.88e-06 | 17 | 98 | 4 | M212 | |
| Pathway | WP_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY | 4.88e-06 | 17 | 98 | 4 | MM15944 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 6.42e-06 | 6 | 98 | 3 | M27068 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 1.04e-05 | 72 | 98 | 6 | M39403 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 1.13e-05 | 73 | 98 | 6 | MM15906 | |
| Pathway | WP_COMPLEMENT_ACTIVATION | 1.46e-05 | 22 | 98 | 4 | M39502 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 1.98e-05 | 48 | 98 | 5 | M27642 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 2.48e-05 | 25 | 98 | 4 | M39713 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 2.54e-05 | 84 | 98 | 6 | MM14653 | |
| Pathway | BIOCARTA_ALTERNATIVE_PATHWAY | 2.65e-05 | 9 | 98 | 3 | M22072 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 2.72e-05 | 85 | 98 | 6 | M16441 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 3.41e-05 | 27 | 98 | 4 | M39545 | |
| Pathway | REACTOME_REGULATION_OF_COMMISSURAL_AXON_PATHFINDING_BY_SLIT_AND_ROBO | 3.77e-05 | 10 | 98 | 3 | M27348 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 5.16e-05 | 11 | 98 | 3 | M47865 | |
| Pathway | WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY | 6.85e-05 | 12 | 98 | 3 | M48316 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 6.85e-05 | 12 | 98 | 3 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 6.85e-05 | 12 | 98 | 3 | M47533 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 8.86e-05 | 13 | 98 | 3 | M47423 | |
| Pathway | WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3 | 8.86e-05 | 13 | 98 | 3 | M42551 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 8.86e-05 | 13 | 98 | 3 | M47534 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 8.86e-05 | 13 | 98 | 3 | M4732 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 1.35e-04 | 38 | 98 | 4 | MM14874 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 1.40e-04 | 15 | 98 | 3 | M7146 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 1.48e-04 | 115 | 98 | 6 | M19752 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.83e-04 | 76 | 98 | 5 | M27219 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 2.20e-04 | 43 | 98 | 4 | M53 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 2.46e-04 | 18 | 98 | 3 | M614 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 3.11e-04 | 47 | 98 | 4 | M646 | |
| Pathway | REACTOME_DEFECTIVE_B4GALT7_CAUSES_EDS_PROGEROID_TYPE | 3.41e-04 | 20 | 98 | 3 | M27258 | |
| Pathway | BIOCARTA_COMP_PATHWAY | 3.41e-04 | 20 | 98 | 3 | M917 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 4.29e-04 | 140 | 98 | 6 | M587 | |
| Pathway | REACTOME_EXTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION | 4.72e-04 | 5 | 98 | 2 | M26948 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 4.72e-04 | 5 | 98 | 2 | MM14733 | |
| Pathway | REACTOME_EXTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION | 4.72e-04 | 5 | 98 | 2 | MM14556 | |
| Pathway | WP_VITAMIN_B12_METABOLISM | 5.32e-04 | 54 | 98 | 4 | M39337 | |
| Pathway | KEGG_DORSO_VENTRAL_AXIS_FORMATION | 5.93e-04 | 24 | 98 | 3 | M11190 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 6.55e-04 | 100 | 98 | 5 | M27158 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 7.46e-04 | 59 | 98 | 4 | M27218 | |
| Pathway | PID_NOTCH_PATHWAY | 7.46e-04 | 59 | 98 | 4 | M17 | |
| Pathway | REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS | 7.54e-04 | 26 | 98 | 3 | M708 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 9.41e-04 | 28 | 98 | 3 | M6177 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 9.67e-04 | 109 | 98 | 5 | MM15164 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 9.82e-04 | 7 | 98 | 2 | MM14734 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.05e-03 | 111 | 98 | 5 | M27416 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 1.14e-03 | 66 | 98 | 4 | M18 | |
| Pathway | BIOCARTA_ALTERNATIVE_PATHWAY | 1.30e-03 | 8 | 98 | 2 | MM1582 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 1.30e-03 | 8 | 98 | 2 | M47850 | |
| Pathway | WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT | 1.67e-03 | 34 | 98 | 3 | M39390 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.92e-03 | 76 | 98 | 4 | MM14867 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 2.02e-03 | 77 | 98 | 4 | MM14670 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_CLEARANCE | 2.13e-03 | 37 | 98 | 3 | M27847 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.48e-03 | 39 | 98 | 3 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.48e-03 | 39 | 98 | 3 | MM15165 | |
| Pathway | REACTOME_INTERACTION_WITH_CUMULUS_CELLS_AND_THE_ZONA_PELLUCIDA | 2.53e-03 | 11 | 98 | 2 | M27184 | |
| Pathway | REACTOME_INTERACTION_WITH_CUMULUS_CELLS_AND_THE_ZONA_PELLUCIDA | 2.53e-03 | 11 | 98 | 2 | MM14897 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 2.53e-03 | 11 | 98 | 2 | MM1430 | |
| Pathway | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | 2.57e-03 | 198 | 98 | 6 | M18311 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 2.77e-03 | 84 | 98 | 4 | M7098 | |
| Pathway | PID_AMB2_NEUTROPHILS_PATHWAY | 2.87e-03 | 41 | 98 | 3 | M159 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM | 2.87e-03 | 41 | 98 | 3 | M27257 | |
| Pathway | BIOCARTA_HES_PATHWAY | 3.02e-03 | 12 | 98 | 2 | MM1562 | |
| Pathway | BIOCARTA_HES_PATHWAY | 3.02e-03 | 12 | 98 | 2 | M22042 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 3.02e-03 | 12 | 98 | 2 | MM1368 | |
| Pathway | REACTOME_VITAMIN_D_CALCIFEROL_METABOLISM | 3.02e-03 | 12 | 98 | 2 | M27088 | |
| Pathway | WP_ALLOGRAFT_REJECTION | 3.41e-03 | 89 | 98 | 4 | M39398 | |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 3.51e-03 | 44 | 98 | 3 | M875 | |
| Pathway | BIOCARTA_EXTRINSIC_PATHWAY | 3.55e-03 | 13 | 98 | 2 | M4470 | |
| Pathway | BIOCARTA_EXTRINSIC_PATHWAY | 3.55e-03 | 13 | 98 | 2 | MM1395 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 3.74e-03 | 45 | 98 | 3 | M39571 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 3.74e-03 | 45 | 98 | 3 | MM15344 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 3.98e-03 | 46 | 98 | 3 | MM15971 | |
| Pathway | PID_PS1_PATHWAY | 3.98e-03 | 46 | 98 | 3 | M70 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 4.12e-03 | 14 | 98 | 2 | MM14923 | |
| Pathway | REACTOME_DEFECTIVE_EXT2_CAUSES_EXOSTOSES_2 | 4.12e-03 | 14 | 98 | 2 | M27263 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 4.15e-03 | 94 | 98 | 4 | M1041 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 4.23e-03 | 47 | 98 | 3 | MM14925 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 4.23e-03 | 47 | 98 | 3 | M7946 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 4.38e-03 | 154 | 98 | 5 | M39739 | |
| Pubmed | HSPG2 FBLN5 VTN SSPOP SLIT2 FBLN2 FBN1 FBN2 HMCN1 LTBP2 DMBT1 AGRN | 1.76e-12 | 175 | 124 | 12 | 28071719 | |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | VLDLR PLXDC1 LRP1B ITGB2 LDLR LRP1 LRP2 NOTCH1 NOTCH2 NOTCH3 | 3.35e-12 | 101 | 124 | 10 | 23382219 |
| Pubmed | 4.29e-12 | 71 | 124 | 9 | 33541421 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | VEGFC HSPG2 FBLN5 CFI LDLR SVEP1 TFPI SLIT2 FBLN2 FBN1 SLIT3 LTBP2 AGRN | 6.12e-12 | 248 | 124 | 13 | 24006456 |
| Pubmed | 9.58e-12 | 257 | 124 | 13 | 16335952 | ||
| Pubmed | 7.78e-11 | 64 | 124 | 8 | 22261194 | ||
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 9.44e-11 | 21 | 124 | 6 | 21337463 | |
| Pubmed | 2.87e-10 | 75 | 124 | 8 | 20637190 | ||
| Pubmed | 7.67e-10 | 5 | 124 | 4 | 19047013 | ||
| Pubmed | 7.67e-10 | 5 | 124 | 4 | 10551839 | ||
| Pubmed | 7.67e-10 | 5 | 124 | 4 | 18685438 | ||
| Pubmed | Stage-specific association of apolipoprotein A-I and E in developing mouse retina. | 1.04e-09 | 14 | 124 | 5 | 17389516 | |
| Pubmed | 1.53e-09 | 32 | 124 | 6 | 18842294 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | HSPG2 FBLN5 TFPI2 ITGAV LRP1B LDLR TFPI FBN1 FBN2 STC2 LRP1 LRP6 PLAUR LTBP2 LTBP3 AGRN PBXIP1 NOTCH1 NOTCH2 NOTCH3 SORL1 | 1.71e-09 | 1201 | 124 | 21 | 35696571 |
| Pubmed | Assembly and regulation of the membrane attack complex based on structures of C5b6 and sC5b9. | 2.30e-09 | 6 | 124 | 4 | 22832194 | |
| Pubmed | 2.97e-09 | 146 | 124 | 9 | 27068509 | ||
| Pubmed | CryoEM reveals how the complement membrane attack complex ruptures lipid bilayers. | 5.34e-09 | 7 | 124 | 4 | 30552328 | |
| Pubmed | 5.34e-09 | 7 | 124 | 4 | 12169628 | ||
| Pubmed | 5.93e-09 | 19 | 124 | 5 | 25691540 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | HSPG2 MGAM FBLN5 VTN CILP MUC5B CUBN CFI ITGAV HMCN1 PROM2 LRP2 LTBP2 C6 C8A C8B C9 PZP AGRN | 8.69e-09 | 1070 | 124 | 19 | 23533145 |
| Pubmed | 9.67e-09 | 167 | 124 | 9 | 22159717 | ||
| Pubmed | Targeted inactivation of the mouse alpha 2-macroglobulin gene. | 1.91e-08 | 9 | 124 | 4 | 7544347 | |
| Pubmed | 1.91e-08 | 9 | 124 | 4 | 20005821 | ||
| Pubmed | 2.54e-08 | 50 | 124 | 6 | 23658023 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 2.63e-08 | 86 | 124 | 7 | 28327460 | |
| Pubmed | 4.42e-08 | 3 | 124 | 3 | 9813312 | ||
| Pubmed | 4.42e-08 | 3 | 124 | 3 | 27697639 | ||
| Pubmed | Intraislet SLIT-ROBO signaling is required for beta-cell survival and potentiates insulin secretion. | 4.42e-08 | 3 | 124 | 3 | 24065825 | |
| Pubmed | 4.42e-08 | 3 | 124 | 3 | 25546260 | ||
| Pubmed | Slit-mediated repulsion is a key regulator of motor axon pathfinding in the hindbrain. | 4.42e-08 | 3 | 124 | 3 | 16162649 | |
| Pubmed | 4.42e-08 | 3 | 124 | 3 | 7615640 | ||
| Pubmed | 4.42e-08 | 3 | 124 | 3 | 7918097 | ||
| Pubmed | Overlapping but distinct roles for NOTCH receptors in human cardiovascular disease. | 4.42e-08 | 3 | 124 | 3 | 29767458 | |
| Pubmed | 4.42e-08 | 3 | 124 | 3 | 7698746 | ||
| Pubmed | 4.42e-08 | 3 | 124 | 3 | 8645602 | ||
| Pubmed | 4.42e-08 | 3 | 124 | 3 | 16840550 | ||
| Pubmed | 4.42e-08 | 3 | 124 | 3 | 18367731 | ||
| Pubmed | Expression of Notch1 to -4 and their ligands in renal cell carcinoma: a tissue microarray study. | 4.42e-08 | 3 | 124 | 3 | 21471519 | |
| Pubmed | Conserved modularity and potential for alternate splicing in mouse and human Slit genes. | 4.42e-08 | 3 | 124 | 3 | 12141424 | |
| Pubmed | 4.98e-08 | 11 | 124 | 4 | 24639464 | ||
| Pubmed | Notch signaling in stomach epithelial stem cell homeostasis. | 5.89e-08 | 29 | 124 | 5 | 21402740 | |
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 6.08e-08 | 97 | 124 | 7 | 27559042 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | FBLN5 HNRNPUL1 STAB1 SLIT2 FBLN2 FBN1 SLIT1 LTBP3 CPLANE1 AGRN NOTCH1 NOTCH2 NOTCH3 | 1.15e-07 | 560 | 124 | 13 | 21653829 |
| Pubmed | 1.50e-07 | 14 | 124 | 4 | 15082773 | ||
| Pubmed | 1.76e-07 | 4 | 124 | 3 | 28669409 | ||
| Pubmed | Heparin/heparan sulfate controls fibrillin-1, -2 and -3 self-interactions in microfibril assembly. | 1.76e-07 | 4 | 124 | 3 | 25034023 | |
| Pubmed | 1.76e-07 | 4 | 124 | 3 | 11401408 | ||
| Pubmed | Slits contribute to the guidance of retinal ganglion cell axons in the mammalian optic tract. | 1.76e-07 | 4 | 124 | 3 | 16828733 | |
| Pubmed | Functional conservation of mouse Notch receptor family members. | 1.76e-07 | 4 | 124 | 3 | 8898100 | |
| Pubmed | 1.76e-07 | 4 | 124 | 3 | 11978185 | ||
| Pubmed | 1.76e-07 | 4 | 124 | 3 | 15863833 | ||
| Pubmed | Deregulated expression of Notch receptors in human hepatocellular carcinoma. | 1.76e-07 | 4 | 124 | 3 | 17920003 | |
| Pubmed | 1.76e-07 | 4 | 124 | 3 | 16618117 | ||
| Pubmed | Prognostic roles of mRNA expression of notch receptors in non-small cell lung cancer. | 1.76e-07 | 4 | 124 | 3 | 28061457 | |
| Pubmed | 1.76e-07 | 4 | 124 | 3 | 11466531 | ||
| Pubmed | 1.76e-07 | 4 | 124 | 3 | 24151014 | ||
| Pubmed | Evidence that C5b recognizes and mediates C8 incorporation into the cytolytic complex of complement. | 1.76e-07 | 4 | 124 | 3 | 3624872 | |
| Pubmed | 1.76e-07 | 4 | 124 | 3 | 10433822 | ||
| Pubmed | Mutational analysis of NOTCH1, 2, 3 and 4 genes in common solid cancers and acute leukemias. | 1.76e-07 | 4 | 124 | 3 | 18184405 | |
| Pubmed | Notch signaling in the mammalian central nervous system: insights from mouse mutants. | 1.76e-07 | 4 | 124 | 3 | 15917835 | |
| Pubmed | 1.76e-07 | 4 | 124 | 3 | 24145721 | ||
| Pubmed | 1.76e-07 | 4 | 124 | 3 | 20069356 | ||
| Pubmed | Expression and clinical significance of Notch receptors in human renal cell carcinoma. | 1.76e-07 | 4 | 124 | 3 | 19404845 | |
| Pubmed | 1.76e-07 | 4 | 124 | 3 | 10551863 | ||
| Pubmed | Developmental regulation of LR11 expression in murine brain. | 1.76e-07 | 4 | 124 | 3 | 9726247 | |
| Pubmed | 1.76e-07 | 4 | 124 | 3 | 15610515 | ||
| Pubmed | 1.76e-07 | 4 | 124 | 3 | 23444212 | ||
| Pubmed | 1.76e-07 | 4 | 124 | 3 | 15840700 | ||
| Pubmed | Novel MIR143-NOTCH fusions in benign and malignant glomus tumors. | 1.76e-07 | 4 | 124 | 3 | 23999936 | |
| Pubmed | Notch as a mediator of cell fate determination in hematopoiesis: evidence and speculation. | 1.76e-07 | 4 | 124 | 3 | 10194420 | |
| Pubmed | 1.76e-07 | 4 | 124 | 3 | 18156632 | ||
| Pubmed | 1.76e-07 | 4 | 124 | 3 | 11459941 | ||
| Pubmed | 2.35e-07 | 118 | 124 | 7 | 21078624 | ||
| Pubmed | 3.59e-07 | 41 | 124 | 5 | 22675208 | ||
| Pubmed | On the topographic targeting of basal vomeronasal axons through Slit-mediated chemorepulsion. | 4.40e-07 | 5 | 124 | 3 | 12954717 | |
| Pubmed | 4.40e-07 | 5 | 124 | 3 | 28234971 | ||
| Pubmed | Slit proteins are not dominant chemorepellents for olfactory tract and spinal motor axons. | 4.40e-07 | 5 | 124 | 3 | 11748139 | |
| Pubmed | 4.40e-07 | 5 | 124 | 3 | 12609596 | ||
| Pubmed | 4.40e-07 | 5 | 124 | 3 | 27040987 | ||
| Pubmed | 4.40e-07 | 5 | 124 | 3 | 21124806 | ||
| Pubmed | Modification of kidney barrier function by the urokinase receptor. | 4.40e-07 | 5 | 124 | 3 | 18084301 | |
| Pubmed | 4.40e-07 | 5 | 124 | 3 | 23675950 | ||
| Pubmed | 4.40e-07 | 5 | 124 | 3 | 30700132 | ||
| Pubmed | Extracellular Ig domains 1 and 2 of Robo are important for ligand (Slit) binding. | 4.40e-07 | 5 | 124 | 3 | 15207848 | |
| Pubmed | 4.40e-07 | 5 | 124 | 3 | 12242712 | ||
| Pubmed | 4.40e-07 | 5 | 124 | 3 | 11520671 | ||
| Pubmed | 4.40e-07 | 5 | 124 | 3 | 12746448 | ||
| Pubmed | Apolipoprotein CI inhibits scavenger receptor BI and increases plasma HDL levels in vivo. | 4.40e-07 | 5 | 124 | 3 | 18992221 | |
| Pubmed | Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance. | 4.40e-07 | 5 | 124 | 3 | 23959870 | |
| Pubmed | Notch signaling in bulge stem cells is not required for selection of hair follicle fate. | 4.40e-07 | 5 | 124 | 3 | 19211676 | |
| Pubmed | Absence of apolipoprotein E protects mice from cerebral malaria. | 4.40e-07 | 5 | 124 | 3 | 27647324 | |
| Pubmed | A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia. | 4.40e-07 | 5 | 124 | 3 | 21562564 | |
| Pubmed | 4.40e-07 | 5 | 124 | 3 | 11101851 | ||
| Pubmed | Development, composition, and structural arrangements of the ciliary zonule of the mouse. | 4.40e-07 | 5 | 124 | 3 | 23493297 | |
| Pubmed | 4.40e-07 | 5 | 124 | 3 | 8013374 | ||
| Pubmed | Functional diversity of notch family genes in fetal lung development. | 4.40e-07 | 5 | 124 | 3 | 15064243 | |
| Pubmed | 4.40e-07 | 5 | 124 | 3 | 15076712 | ||
| Pubmed | 4.40e-07 | 5 | 124 | 3 | 17255108 | ||
| Pubmed | 4.40e-07 | 5 | 124 | 3 | 15882997 | ||
| Pubmed | 4.53e-07 | 18 | 124 | 4 | 10827173 | ||
| Interaction | NTN5 interactions | 9.01e-17 | 24 | 123 | 10 | int:NTN5 | |
| Interaction | ZFP41 interactions | FBLN5 LRP1B LDLR FBN1 FBN2 LRP1 LRP2 AGRN NOTCH2 NOTCH3 SORL1 | 4.04e-14 | 57 | 123 | 11 | int:ZFP41 |
| Interaction | ZNF408 interactions | KCTD9 HSPG2 VLDLR FBLN5 LRP1B LDLR FBLN2 FBN1 FBN2 LRP2 LTBP2 NOTCH2 NOTCH3 SORL1 | 2.60e-13 | 145 | 123 | 14 | int:ZNF408 |
| Interaction | IGFL3 interactions | VLDLR FBLN5 LRP1B LDLR FBN2 LRP2 AGRN NOTCH1 NOTCH2 NOTCH3 SORL1 | 9.78e-13 | 75 | 123 | 11 | int:IGFL3 |
| Interaction | DAB1 interactions | 1.90e-08 | 107 | 123 | 9 | int:DAB1 | |
| Interaction | ZDHHC15 interactions | 7.38e-08 | 125 | 123 | 9 | int:ZDHHC15 | |
| Interaction | CCN6 interactions | 8.47e-08 | 19 | 123 | 5 | int:CCN6 | |
| Interaction | ZNF224 interactions | 1.12e-07 | 20 | 123 | 5 | int:ZNF224 | |
| Interaction | PRG2 interactions | HSPG2 ADAM21 ITGAV LDLR FBN2 LRP6 LTBP3 PBXIP1 NOTCH1 NOTCH2 NOTCH3 SORL1 | 1.81e-07 | 285 | 123 | 12 | int:PRG2 |
| Interaction | ZNF696 interactions | 1.89e-07 | 68 | 123 | 7 | int:ZNF696 | |
| Interaction | FBXO2 interactions | HSPG2 ITGAV LRP1B BRAP SLIT2 FBN1 FBN2 LRP2 C8A AGRN NOTCH1 NOTCH2 NOTCH3 SORL1 | 2.21e-07 | 411 | 123 | 14 | int:FBXO2 |
| Interaction | EGFL7 interactions | 4.48e-07 | 77 | 123 | 7 | int:EGFL7 | |
| Interaction | FOXD4L6 interactions | 5.16e-07 | 49 | 123 | 6 | int:FOXD4L6 | |
| Interaction | GLI4 interactions | 9.92e-07 | 125 | 123 | 8 | int:GLI4 | |
| Interaction | IGSF5 interactions | 1.26e-06 | 14 | 123 | 4 | int:IGSF5 | |
| Interaction | ZNF74 interactions | 1.88e-06 | 34 | 123 | 5 | int:ZNF74 | |
| Interaction | HOXA1 interactions | KCTD9 FBLN5 ARID5A SLIT2 FBLN2 FBN1 OIT3 SLIT1 LTBP3 AGRN NOTCH1 NOTCH3 | 1.90e-06 | 356 | 123 | 12 | int:HOXA1 |
| Interaction | DLK2 interactions | 2.53e-06 | 36 | 123 | 5 | int:DLK2 | |
| Interaction | APOA1 interactions | 2.89e-06 | 193 | 123 | 9 | int:APOA1 | |
| Interaction | GREM2 interactions | 2.91e-06 | 37 | 123 | 5 | int:GREM2 | |
| Interaction | EDN3 interactions | 4.45e-06 | 108 | 123 | 7 | int:EDN3 | |
| Interaction | ST14 interactions | 5.12e-06 | 207 | 123 | 9 | int:ST14 | |
| Interaction | ZNF627 interactions | 5.94e-06 | 20 | 123 | 4 | int:ZNF627 | |
| Interaction | EGFL6 interactions | 7.30e-06 | 21 | 123 | 4 | int:EGFL6 | |
| Interaction | ZNF594 interactions | 7.63e-06 | 7 | 123 | 3 | int:ZNF594 | |
| Interaction | TAFA3 interactions | 8.20e-06 | 78 | 123 | 6 | int:TAFA3 | |
| Interaction | ZNF324 interactions | 8.76e-06 | 46 | 123 | 5 | int:ZNF324 | |
| Interaction | ZNF707 interactions | 8.83e-06 | 79 | 123 | 6 | int:ZNF707 | |
| Interaction | ZNF77 interactions | 8.88e-06 | 22 | 123 | 4 | int:ZNF77 | |
| Interaction | PI15 interactions | 1.18e-05 | 83 | 123 | 6 | int:PI15 | |
| Interaction | WNT3A interactions | 1.20e-05 | 49 | 123 | 5 | int:WNT3A | |
| Interaction | PRG3 interactions | 1.20e-05 | 49 | 123 | 5 | int:PRG3 | |
| Interaction | DKK2 interactions | 1.20e-05 | 49 | 123 | 5 | int:DKK2 | |
| Interaction | ZNF765 interactions | 1.28e-05 | 24 | 123 | 4 | int:ZNF765 | |
| Interaction | FBLN1 interactions | 1.43e-05 | 129 | 123 | 7 | int:FBLN1 | |
| Interaction | KLK10 interactions | 1.49e-05 | 180 | 123 | 8 | int:KLK10 | |
| Interaction | MFAP5 interactions | 1.61e-05 | 52 | 123 | 5 | int:MFAP5 | |
| Interaction | C8B interactions | 1.81e-05 | 9 | 123 | 3 | int:C8B | |
| Interaction | LTBP1 interactions | 2.12e-05 | 92 | 123 | 6 | int:LTBP1 | |
| Interaction | CTSG interactions | 2.55e-05 | 95 | 123 | 6 | int:CTSG | |
| Interaction | ELN interactions | 2.79e-05 | 29 | 123 | 4 | int:ELN | |
| Interaction | ANKRD36B interactions | 3.26e-05 | 60 | 123 | 5 | int:ANKRD36B | |
| Interaction | HRG interactions | 4.13e-05 | 63 | 123 | 5 | int:HRG | |
| Interaction | SCGB1A1 interactions | 4.69e-05 | 12 | 123 | 3 | int:SCGB1A1 | |
| Interaction | ZNF101 interactions | 4.71e-05 | 33 | 123 | 4 | int:ZNF101 | |
| Interaction | FBN2 interactions | 4.81e-05 | 65 | 123 | 5 | int:FBN2 | |
| Interaction | ASPHD2 interactions | 5.32e-05 | 34 | 123 | 4 | int:ASPHD2 | |
| Interaction | ZNF709 interactions | 6.07e-05 | 13 | 123 | 3 | int:ZNF709 | |
| Interaction | ZNF235 interactions | 6.07e-05 | 13 | 123 | 3 | int:ZNF235 | |
| Interaction | OSER1 interactions | 6.07e-05 | 13 | 123 | 3 | int:OSER1 | |
| Interaction | NOTCH3 interactions | 6.78e-05 | 113 | 123 | 6 | int:NOTCH3 | |
| Interaction | WNT10A interactions | 7.47e-05 | 37 | 123 | 4 | int:WNT10A | |
| Interaction | APOE interactions | 8.71e-05 | 171 | 123 | 7 | int:APOE | |
| Interaction | CUBN interactions | 9.57e-05 | 15 | 123 | 3 | int:CUBN | |
| Interaction | C5 interactions | 1.02e-04 | 40 | 123 | 4 | int:C5 | |
| Interaction | DEFB123 interactions | 1.17e-04 | 16 | 123 | 3 | int:DEFB123 | |
| Interaction | ZNF628 interactions | 1.17e-04 | 16 | 123 | 3 | int:ZNF628 | |
| Interaction | CFC1 interactions | 1.24e-04 | 126 | 123 | 6 | int:CFC1 | |
| Interaction | THBS1 interactions | 1.29e-04 | 127 | 123 | 6 | int:THBS1 | |
| Interaction | C9 interactions | 1.42e-04 | 17 | 123 | 3 | int:C9 | |
| Interaction | MAML2 interactions | 1.42e-04 | 17 | 123 | 3 | int:MAML2 | |
| Interaction | DEFB136 interactions | 1.49e-04 | 44 | 123 | 4 | int:DEFB136 | |
| Interaction | ATN1 interactions | 1.52e-04 | 187 | 123 | 7 | int:ATN1 | |
| Interaction | LRP1B interactions | 1.73e-04 | 85 | 123 | 5 | int:LRP1B | |
| Interaction | PLAUR interactions | 1.81e-04 | 135 | 123 | 6 | int:PLAUR | |
| Interaction | SIRPD interactions | 1.83e-04 | 86 | 123 | 5 | int:SIRPD | |
| Interaction | ZNF865 interactions | 1.92e-04 | 47 | 123 | 4 | int:ZNF865 | |
| Interaction | ZNF358 interactions | 2.00e-04 | 19 | 123 | 3 | int:ZNF358 | |
| Interaction | NID1 interactions | 2.09e-04 | 48 | 123 | 4 | int:NID1 | |
| Interaction | TIMP3 interactions | 2.27e-04 | 90 | 123 | 5 | int:TIMP3 | |
| Interaction | MAML3 interactions | 2.34e-04 | 20 | 123 | 3 | int:MAML3 | |
| Interaction | MDK interactions | 2.39e-04 | 91 | 123 | 5 | int:MDK | |
| Interaction | HGF interactions | 2.65e-04 | 51 | 123 | 4 | int:HGF | |
| Interaction | FBN1 interactions | 2.65e-04 | 51 | 123 | 4 | int:FBN1 | |
| Interaction | CLEC2B interactions | 2.87e-04 | 147 | 123 | 6 | int:CLEC2B | |
| Interaction | CASR interactions | 3.14e-04 | 22 | 123 | 3 | int:CASR | |
| Interaction | C8A interactions | 3.14e-04 | 22 | 123 | 3 | int:C8A | |
| Interaction | SERPINE1 interactions | 3.30e-04 | 54 | 123 | 4 | int:SERPINE1 | |
| Interaction | WNT2 interactions | 3.59e-04 | 23 | 123 | 3 | int:WNT2 | |
| Interaction | ZNF282 interactions | 3.59e-04 | 23 | 123 | 3 | int:ZNF282 | |
| Interaction | DPY19L3 interactions | 4.09e-04 | 24 | 123 | 3 | int:DPY19L3 | |
| Interaction | WNT10B interactions | 4.63e-04 | 25 | 123 | 3 | int:WNT10B | |
| Interaction | SENP5 interactions | 4.64e-04 | 59 | 123 | 4 | int:SENP5 | |
| Interaction | ZNF444 interactions | 4.84e-04 | 106 | 123 | 5 | int:ZNF444 | |
| Interaction | TGFB2 interactions | 5.21e-04 | 26 | 123 | 3 | int:TGFB2 | |
| Interaction | GC interactions | 5.61e-04 | 62 | 123 | 4 | int:GC | |
| Interaction | JAG2 interactions | 5.73e-04 | 110 | 123 | 5 | int:JAG2 | |
| Interaction | ETV7 interactions | 5.83e-04 | 27 | 123 | 3 | int:ETV7 | |
| Interaction | HBM interactions | 5.83e-04 | 27 | 123 | 3 | int:HBM | |
| Interaction | ZNF320 interactions | 5.83e-04 | 27 | 123 | 3 | int:ZNF320 | |
| Interaction | EMILIN2 interactions | 5.83e-04 | 27 | 123 | 3 | int:EMILIN2 | |
| Interaction | FEZF1 interactions | 6.50e-04 | 28 | 123 | 3 | int:FEZF1 | |
| Interaction | ZNF430 interactions | 7.22e-04 | 29 | 123 | 3 | int:ZNF430 | |
| Interaction | ZNF517 interactions | 7.22e-04 | 29 | 123 | 3 | int:ZNF517 | |
| Interaction | LTBP4 interactions | 7.53e-04 | 67 | 123 | 4 | int:LTBP4 | |
| Interaction | ZNF253 interactions | 7.61e-04 | 7 | 123 | 2 | int:ZNF253 | |
| Interaction | CLU interactions | 7.74e-04 | 245 | 123 | 7 | int:CLU | |
| Interaction | ADAM9 interactions | 8.19e-04 | 119 | 123 | 5 | int:ADAM9 | |
| Interaction | LRPAP1 interactions | 8.37e-04 | 180 | 123 | 6 | int:LRPAP1 | |
| Interaction | CILP2 interactions | 8.80e-04 | 31 | 123 | 3 | int:CILP2 | |
| Cytoband | 8p11.22 | 6.45e-04 | 14 | 124 | 2 | 8p11.22 | |
| Cytoband | 6q12 | 1.61e-03 | 22 | 124 | 2 | 6q12 | |
| Cytoband | 10p12.31 | 1.61e-03 | 22 | 124 | 2 | 10p12.31 | |
| Cytoband | 5q35 | 1.76e-03 | 23 | 124 | 2 | 5q35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q12 | 2.25e-03 | 26 | 124 | 2 | chr6q12 | |
| Cytoband | 1p32 | 2.43e-03 | 27 | 124 | 2 | 1p32 | |
| Cytoband | 9q34.3 | 3.03e-03 | 106 | 124 | 3 | 9q34.3 | |
| GeneFamily | Low density lipoprotein receptors | 5.10e-14 | 13 | 82 | 7 | 634 | |
| GeneFamily | Complement system|Sushi domain containing | 1.26e-08 | 36 | 82 | 6 | 492 | |
| GeneFamily | Fibulins | 2.71e-08 | 8 | 82 | 4 | 556 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 6.37e-06 | 27 | 82 | 4 | 47 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily B | 6.08e-05 | 3 | 82 | 2 | 912 | |
| GeneFamily | Latent transforming growth factor beta binding proteins | 1.21e-04 | 4 | 82 | 2 | 628 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.29e-04 | 57 | 82 | 4 | 1179 | |
| GeneFamily | Blood group antigens|CD molecules|Proteoglycans | 4.20e-04 | 7 | 82 | 2 | 570 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 3.30e-03 | 19 | 82 | 2 | 50 | |
| GeneFamily | CD molecules|Mucins | 4.03e-03 | 21 | 82 | 2 | 648 | |
| GeneFamily | PWWP domain containing | 4.43e-03 | 22 | 82 | 2 | 1147 | |
| GeneFamily | PHD finger proteins | 7.96e-03 | 90 | 82 | 3 | 88 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 1.04e-02 | 34 | 82 | 2 | 487 | |
| GeneFamily | Zinc fingers CCCH-type | 1.10e-02 | 35 | 82 | 2 | 73 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | FBLN7 FBLN5 VTN CILP SSPOP SVEP1 ZP1 SLIT2 EYS FBLN2 FBN1 FBN2 OIT3 HMCN1 SLIT1 SLIT3 LTBP2 LTBP3 DMBT1 AGRN FBN3 | 9.54e-23 | 196 | 123 | 21 | M3008 |
| Coexpression | NABA_CORE_MATRISOME | HSPG2 FBLN7 FBLN5 VTN CILP SSPOP SVEP1 ZP1 SLIT2 EYS FBLN2 FBN1 FBN2 OIT3 HMCN1 NCAN SLIT1 SLIT3 LTBP2 LTBP3 DMBT1 AGRN FBN3 | 2.36e-22 | 275 | 123 | 23 | M5884 |
| Coexpression | NABA_MATRISOME | VEGFC HSPG2 FBLN7 FBLN5 VTN CILP PLXDC1 ADAM21 ADAM18 MUC5B ADAMTS8 ADAM32 ADAM8 SSPOP F7 SVEP1 ZP1 SLIT2 EYS FBLN2 FBN1 FBN2 OIT3 SCUBE2 HMCN1 NCAN SLIT1 SLIT3 ADAMTS20 LTBP2 LTBP3 DMBT1 PZP MUC5AC AGRN FBN3 | 7.07e-22 | 1026 | 123 | 36 | M5889 |
| Coexpression | NABA_MATRISOME | VEGFC HSPG2 FBLN7 FBLN5 VTN CILP PLXDC1 ADAM21 ADAM18 MUC5B ADAMTS8 ADAM32 ADAM8 SSPOP F7 SVEP1 ZP1 SLIT2 FBLN2 FBN1 FBN2 OIT3 SCUBE2 HMCN1 NCAN SLIT1 SLIT3 ADAMTS20 LTBP2 LTBP3 DMBT1 PZP MUC5AC AGRN | 4.24e-20 | 1008 | 123 | 34 | MM17056 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | FBLN7 FBLN5 VTN CILP SSPOP SVEP1 ZP1 SLIT2 FBLN2 FBN1 FBN2 OIT3 HMCN1 SLIT1 SLIT3 LTBP2 LTBP3 DMBT1 AGRN | 4.93e-20 | 191 | 123 | 19 | MM17059 |
| Coexpression | NABA_CORE_MATRISOME | HSPG2 FBLN7 FBLN5 VTN CILP SSPOP SVEP1 ZP1 SLIT2 FBLN2 FBN1 FBN2 OIT3 HMCN1 NCAN SLIT1 SLIT3 LTBP2 LTBP3 DMBT1 AGRN | 8.25e-20 | 270 | 123 | 21 | MM17057 |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | VEGFC FBLN5 TFPI2 ITGAV SLIT2 FBLN2 FBN1 FBN2 SLIT3 LRP1 PLAUR NOTCH2 | 1.92e-10 | 200 | 123 | 12 | M5930 |
| Coexpression | BOQUEST_STEM_CELL_UP | FBLN5 CILP LRP1B SVEP1 SLIT2 FBN1 SLIT3 LRP1 LTBP2 C6 NOTCH2 | 4.46e-08 | 261 | 123 | 11 | M1834 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_OMD_POS_ENDOTHELIAL_CELL | FBLN5 TFPI2 CUBN LDLR ARID5A SLC6A4 FBLN2 FBN2 HMCN1 SLIT3 LTBP2 LDLRAD4 | 1.18e-07 | 355 | 123 | 12 | M45758 |
| Coexpression | OHGUCHI_LIVER_HNF4A_TARGETS_DN | 1.21e-07 | 171 | 123 | 9 | M2194 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN | 2.52e-07 | 135 | 123 | 8 | M5825 | |
| Coexpression | HALLMARK_COAGULATION | 2.98e-07 | 138 | 123 | 8 | M5946 | |
| Coexpression | OHGUCHI_LIVER_HNF4A_TARGETS_DN | 4.75e-07 | 201 | 123 | 9 | MM1294 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 6.08e-07 | 35 | 123 | 5 | MM17054 | |
| Coexpression | TRAVAGLINI_LUNG_ALVEOLAR_FIBROBLAST_CELL | 1.11e-06 | 164 | 123 | 8 | M41676 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2C | ADGRB1 ADGRB3 ITGAV LRP1B FBLN2 SCUBE2 DPF3 NCAN LRP1 NOTCH1 | 3.26e-06 | 325 | 123 | 10 | M39053 |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 3.75e-06 | 50 | 123 | 5 | M1259 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 4.57e-06 | 52 | 123 | 5 | MM1118 | |
| Coexpression | BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A | DOCK4 GPRASP1 KCTD9 FBLN7 ZNF536 VTN ADAMTS8 ADGRL4 SLC6A4 BRCA2 DPF3 NCAN LRP2 TSR3 AGRN ENTPD8 | 4.93e-06 | 899 | 123 | 16 | M2242 |
| Coexpression | BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A | DOCK4 GPRASP1 KCTD9 FBLN7 ZNF536 VTN ADAMTS8 ADGRL4 SLC6A4 BRCA2 DPF3 NCAN LRP2 TSR3 AGRN ENTPD8 | 7.54e-06 | 930 | 123 | 16 | MM893 |
| Coexpression | NABA_MATRISOME_HGSOC_OMENTAL_METASTASIS | 8.57e-06 | 59 | 123 | 5 | M47993 | |
| Coexpression | AIZARANI_LIVER_C20_LSECS_3 | 1.10e-05 | 295 | 123 | 9 | M39121 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP | 1.23e-05 | 163 | 123 | 7 | M12112 | |
| Coexpression | NABA_ECM_REGULATORS | 1.72e-05 | 238 | 123 | 8 | M3468 | |
| Coexpression | NABA_ECM_REGULATORS | 1.94e-05 | 242 | 123 | 8 | MM17062 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | FBLN7 FBLN5 VTN PLXDC1 ADAM8 ITGB2 F7 SVEP1 CCDC148 STAB1 FBLN2 FBN1 OIT3 LACC1 PLAUR LTBP2 LTBP3 C8B | 2.01e-05 | 1242 | 123 | 18 | M1920 |
| Coexpression | HSIAO_LIVER_SPECIFIC_GENES | 2.38e-05 | 249 | 123 | 8 | M13283 | |
| Coexpression | WEINMANN_ADAPTATION_TO_HYPOXIA_DN | 3.01e-05 | 38 | 123 | 4 | M7137 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_DN | 3.92e-05 | 267 | 123 | 8 | M13449 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | FBLN7 FBLN5 VTN PLXDC1 ADAM8 ITGB2 F7 SVEP1 CCDC148 STAB1 FBLN2 FBN1 OIT3 LACC1 PLAUR LTBP2 LTBP3 C8B | 4.28e-05 | 1316 | 123 | 18 | MM1052 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | VEGFC PLXDC1 ADAM21 ADAM18 MUC5B ADAMTS8 ADAM32 ADAM8 F7 SCUBE2 ADAMTS20 PZP MUC5AC | 4.50e-05 | 738 | 123 | 13 | MM17058 |
| Coexpression | ONDER_CDH1_SIGNALING_VIA_CTNNB1 | 4.81e-05 | 84 | 123 | 5 | M15484 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_VENOUS_ENDOTHELIAL_CELL | 5.10e-05 | 85 | 123 | 5 | M45761 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | VEGFC PLXDC1 ADAM21 ADAM18 MUC5B ADAMTS8 ADAM32 ADAM8 F7 SCUBE2 ADAMTS20 PZP MUC5AC | 5.37e-05 | 751 | 123 | 13 | M5885 |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 5.40e-05 | 16 | 123 | 3 | MM1296 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 5.40e-05 | 16 | 123 | 3 | M2207 | |
| Coexpression | MEL18_DN.V1_UP | 5.52e-05 | 141 | 123 | 6 | M2784 | |
| Coexpression | YAGI_AML_WITH_T_8_21_TRANSLOCATION | 6.74e-05 | 372 | 123 | 9 | M19261 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | PLXDC1 TFPI2 ITGAV TFPI FBN1 HMCN1 LACC1 PLAUR LTBP2 NOTCH1 NOTCH2 NOTCH3 | 8.93e-05 | 681 | 123 | 12 | M39175 |
| Coexpression | DESERT_PERIPORTAL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP | 1.07e-04 | 159 | 123 | 6 | M34031 | |
| Coexpression | HORIUCHI_WTAP_TARGETS_UP | 1.09e-04 | 309 | 123 | 8 | M1973 | |
| Coexpression | VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 | 1.22e-04 | 54 | 123 | 4 | M4737 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2A | AKAP6 ADGRB3 ITGAV NCAN SLIT1 LRP1 LRP2 PBXIP1 LDLRAD4 NOTCH1 NOTCH2 | 1.26e-04 | 600 | 123 | 11 | M39055 |
| Coexpression | BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING | 1.32e-04 | 237 | 123 | 7 | M7068 | |
| Coexpression | SERVITJA_LIVER_HNF1A_TARGETS_DN | 1.36e-04 | 166 | 123 | 6 | M2398 | |
| Coexpression | ZHONG_PFC_MAJOR_TYPES_ASTROCYTES | 1.57e-04 | 326 | 123 | 8 | M39074 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_COLORECTAL_TUMOR | 1.72e-04 | 59 | 123 | 4 | M47989 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_FAP_CELLS | 2.05e-04 | 179 | 123 | 6 | M41745 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | PLXDC1 CEP85L MBNL1 RALGAPB HECTD4 NSD1 ADAM8 ITGB2 FAM13B ARID5A DHX9 ANP32E MACF1 PBXIP1 LDLRAD4 NOTCH1 NOTCH2 SORL1 | 2.09e-04 | 1492 | 123 | 18 | M40023 |
| Coexpression | BOCHKIS_FOXA2_TARGETS | 2.15e-04 | 434 | 123 | 9 | M1806 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2B | 2.34e-04 | 439 | 123 | 9 | M39054 | |
| Coexpression | MTOR_UP.N4.V1_DN | 2.38e-04 | 184 | 123 | 6 | M2756 | |
| Coexpression | ATF2_S_UP.V1_DN | 2.59e-04 | 187 | 123 | 6 | M2681 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 2.64e-04 | 352 | 123 | 8 | M17471 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | VEGFC HSPG2 CFI ITGAV LDLR SVEP1 TFPI SLIT2 FBN1 SLIT3 LTBP2 NOTCH3 | 2.68e-04 | 767 | 123 | 12 | M39209 |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_DT_ANTIBODY_CORRELATION_PROFILE_3DY_UP | 2.72e-04 | 27 | 123 | 3 | M40935 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC | 2.72e-04 | 27 | 123 | 3 | M47994 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 2.80e-04 | 268 | 123 | 7 | M45796 | |
| Coexpression | SERVITJA_LIVER_HNF1A_TARGETS_DN | 2.82e-04 | 190 | 123 | 6 | MM1311 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP | 3.15e-04 | 69 | 123 | 4 | M10165 | |
| Coexpression | GSE17301_CTRL_VS_48H_IFNA2_STIM_CD8_TCELL_DN | 3.33e-04 | 196 | 123 | 6 | M8034 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_DN | 3.42e-04 | 197 | 123 | 6 | M4421 | |
| Coexpression | GSE13484_3H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN | 3.52e-04 | 198 | 123 | 6 | M3267 | |
| Coexpression | KRAS.600_UP.V1_UP | 3.57e-04 | 279 | 123 | 7 | M2882 | |
| Coexpression | GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_MACROPHAGE_UP | 3.61e-04 | 199 | 123 | 6 | M8105 | |
| Coexpression | GSE7852_LN_VS_THYMUS_TCONV_UP | 3.61e-04 | 199 | 123 | 6 | M5745 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | PLXDC1 ITGAV SVEP1 TFPI FBN1 LRP1 PLAUR PLCL1 PZP AGRN NOTCH2 NOTCH3 | 3.70e-04 | 795 | 123 | 12 | M39050 |
| Coexpression | GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_3H_DN | 3.71e-04 | 200 | 123 | 6 | M6399 | |
| Coexpression | HALLMARK_COMPLEMENT | 3.71e-04 | 200 | 123 | 6 | M5921 | |
| Coexpression | GSE17721_0.5H_VS_4H_GARDIQUIMOD_BMDC_DN | 3.71e-04 | 200 | 123 | 6 | M4140 | |
| Coexpression | GSE2405_0H_VS_24H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN | 3.71e-04 | 200 | 123 | 6 | M6193 | |
| Coexpression | GSE39820_IL1B_IL6_VS_IL1B_IL6_IL23A_TREATED_CD4_TCELL_DN | 3.71e-04 | 200 | 123 | 6 | M5616 | |
| Coexpression | NABA_MATRISOME_METASTATIC_COLORECTAL_LIVER_METASTASIS | 3.73e-04 | 30 | 123 | 3 | M47990 | |
| Coexpression | RB_P107_DN.V1_UP | 3.76e-04 | 130 | 123 | 5 | M2802 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | FBLN5 SSPOP LRP1B SLIT2 SLIT1 LRP1 LRP2 PBXIP1 LDLRAD4 NOTCH2 | 3.85e-04 | 574 | 123 | 10 | M39056 |
| Coexpression | LINDVALL_IMMORTALIZED_BY_TERT_DN | 3.91e-04 | 73 | 123 | 4 | M1561 | |
| Coexpression | VALK_AML_CLUSTER_13 | 4.12e-04 | 31 | 123 | 3 | M2603 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 4.41e-04 | 479 | 123 | 9 | M2573 | |
| Coexpression | GSE6259_33D1_POS_DC_VS_CD8_TCELL_DN | 4.47e-04 | 135 | 123 | 5 | M6759 | |
| Coexpression | HALLMARK_NOTCH_SIGNALING | 4.53e-04 | 32 | 123 | 3 | M5903 | |
| Coexpression | YAMASHITA_LIVER_CANCER_STEM_CELL_DN | 4.56e-04 | 76 | 123 | 4 | M9206 | |
| Coexpression | HU_FETAL_RETINA_RPE | 4.59e-04 | 291 | 123 | 7 | M39271 | |
| Coexpression | SMID_BREAST_CANCER_BASAL_DN | CILP TFPI2 F7 SVEP1 SLC6A4 SCUBE2 STC2 SLIT3 PLCL1 LDLRAD4 SORL1 | 4.63e-04 | 699 | 123 | 11 | M4960 |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 4.68e-04 | 483 | 123 | 9 | MM1082 | |
| Coexpression | TRAVAGLINI_LUNG_ADVENTITIAL_FIBROBLAST_CELL | 5.08e-04 | 296 | 123 | 7 | M41675 | |
| Coexpression | LI_ESTROGENE_LATE_E2_RESPONSE_DN | 5.55e-04 | 80 | 123 | 4 | M48218 | |
| Coexpression | KRAS.300_UP.V1_UP | 5.81e-04 | 143 | 123 | 5 | M2875 | |
| Coexpression | AIZARANI_LIVER_C9_LSECS_1 | 5.94e-04 | 304 | 123 | 7 | M39113 | |
| Coexpression | HALLMARK_UV_RESPONSE_DN | 6.00e-04 | 144 | 123 | 5 | M5942 | |
| Coexpression | BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS | 6.00e-04 | 8 | 123 | 2 | M9884 | |
| Coexpression | RODWELL_AGING_KIDNEY_UP | 6.09e-04 | 501 | 123 | 9 | M5389 | |
| Coexpression | BMI1_DN.V1_UP | 6.58e-04 | 147 | 123 | 5 | M2782 | |
| Coexpression | RODWELL_AGING_KIDNEY_NO_BLOOD_UP | 6.74e-04 | 224 | 123 | 6 | M9893 | |
| Coexpression | REN_ALVEOLAR_RHABDOMYOSARCOMA_DN | 6.88e-04 | 407 | 123 | 8 | M19541 | |
| Coexpression | SMID_BREAST_CANCER_LUMINAL_A_UP | 6.97e-04 | 85 | 123 | 4 | M7517 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN | 6.97e-04 | 85 | 123 | 4 | M10575 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_MID_BASAL_CELL | 7.00e-04 | 149 | 123 | 5 | M45703 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#2_top-relative-expression-ranked_1000 | VEGFC KCTD9 FBLN5 CILP SVEP1 TFPI FBLN2 FBN1 LACC1 LRP1 LTBP2 LTBP3 | 1.76e-06 | 369 | 124 | 12 | gudmap_kidney_adult_RenalCapsule_k2_1000 |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | VEGFC FBLN7 ZNF536 FBLN5 VTN TMEM8B ADGRB3 DCT SSPOP LRP1B SVEP1 SLIT2 FBLN2 FBN1 FBN2 HMCN1 SLIT1 SLIT3 LRP2 LTBP2 | 5.31e-06 | 1094 | 124 | 20 | ratio_EB_vs_SC_2500_K3 |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | DOCK4 HSPG2 FBLN5 ADGRL4 TFPI STAB1 SLIT2 FBN1 HMCN1 TIE1 LTBP2 AGRN | 1.04e-05 | 439 | 124 | 12 | GSM777059_500 |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_1000 | VEGFC KCTD9 VLDLR FBLN5 CILP MBNL1 SVEP1 TFPI FBLN2 FBN1 HMCN1 LACC1 LRP1 LRP2 LTBP2 LTBP3 | 1.23e-05 | 778 | 124 | 16 | gudmap_kidney_adult_RenalCapsule_1000 |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000 | AKAP6 VEGFC FBLN7 ZNF536 FBLN5 VTN CFI DCT LRP1B SVEP1 SLIT2 FBN1 DPF3 SLIT1 SLIT3 LTBP2 PLCL1 LDLRAD4 | 1.88e-05 | 994 | 124 | 18 | PCBC_ratio_EB_vs_SC_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_DevVasOvary_Flk_top-relative-expression-ranked_500 | VEGFC DOCK4 HSPG2 ADGRL4 TFPI STAB1 OIT3 HMCN1 TIE1 PLCL1 NOTCH1 | 3.26e-05 | 415 | 124 | 11 | gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_500 |
| CoexpressionAtlas | ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | AKAP6 DIPK1C FBLN7 VTN TMEM8B CFI SSPOP LRP1B CCDC148 FBN2 SCUBE2 CRYGN SLIT1 SLIT3 LRP2 PBXIP1 | 3.50e-05 | 848 | 124 | 16 | ratio_ECTO_vs_SC_2500_K3 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500 | 4.65e-05 | 356 | 124 | 10 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500 | 5.60e-05 | 364 | 124 | 10 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500 | |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | DOCK4 HSPG2 FBLN5 ADGRL4 TFPI STAB1 FBN1 HMCN1 TIE1 LTBP2 AGRN | 6.76e-05 | 450 | 124 | 11 | GSM777063_500 |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | VEGFC HSPG2 FBLN5 VTN SVEP1 FBN1 HMCN1 SLIT3 LRP1 LTBP3 NOTCH3 | 9.22e-05 | 466 | 124 | 11 | GSM777050_500 |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_2500_k-means-cluster#1 | VEGFC DOCK4 HSPG2 FBLN7 TFPI2 CUBN CFI ITGAV ADGRL4 TFPI STAB1 SLC6A4 TIE1 PLAUR LTBP2 PZP | 1.12e-04 | 936 | 124 | 16 | JC_hmvEC_2500_K1 |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000 | VEGFC DOCK4 HSPG2 PLXDC1 ADGRL4 TFPI STAB1 SLC6A4 OIT3 HMCN1 TIE1 LACC1 DPF3 PLCL1 NOTCH1 | 1.25e-04 | 846 | 124 | 15 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_1000 |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05 | FBLN5 VTN TMEM8B CUBN CFI MAMDC4 SLIT2 FBN1 OIT3 SLIT3 LRP1 LRP2 LTBP3 C9 PZP NR1I3 MBNL3 | 1.28e-04 | 1049 | 124 | 17 | PCBC_ratio_MESO-15_vs_MESO-5_cfr-2X-p05 |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_2500_k-means-cluster#2 | ZNF536 FBLN5 VTN CUBN DCT SVEP1 FBN1 HMCN1 NCAN SLIT1 SLIT3 LRP2 ADAMTS20 PLAUR LTBP2 FBN3 | 1.34e-04 | 951 | 124 | 16 | Arv_EB-LF_2500_K2 |
| CoexpressionAtlas | MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | HSPG2 FBLN5 VTN CILP TFPI2 CFI ITGAV LDLR SLIT1 SLIT3 PLAUR LTBP2 C6 PZP | 1.45e-04 | 761 | 124 | 14 | PCBC_ratio_MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC_cfr-2X-p05 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.51e-04 | 261 | 124 | 8 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k4_1000 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 1.58e-04 | 87 | 124 | 5 | GSM777050_100 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | PLXDC1 ALPK1 SVEP1 SLIT2 FBLN2 FBN1 FBN2 HMCN1 BRCA2 STC2 LACC1 LRP1 MBNL3 NOTCH2 | 1.60e-04 | 768 | 124 | 14 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_top-relative-expression-ranked_500 | 1.61e-04 | 414 | 124 | 10 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_top-relative-expression-ranked_500 | 1.68e-04 | 416 | 124 | 10 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | FBLN5 PLXDC1 ALPK1 SVEP1 SLIT2 FBN1 FBN2 HMCN1 STC2 LACC1 DPF3 LRP1 MBNL3 NOTCH2 | 1.71e-04 | 773 | 124 | 14 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500 | 1.74e-04 | 418 | 124 | 10 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500 | |
| CoexpressionAtlas | liver | 1.78e-04 | 419 | 124 | 10 | liver | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_1000 | VEGFC FBLN5 TFPI2 SVEP1 ADGRL4 TFPI SLC6A4 FBLN2 FBN1 HMCN1 STC2 SLIT3 LRP1 PLAUR LTBP2 PLCL1 | 1.79e-04 | 975 | 124 | 16 | PCBC_ctl_CardiacMyocyte_1000 |
| CoexpressionAtlas | geo_heart_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.95e-04 | 424 | 124 | 10 | geo_heart_1000_K5 | |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_top-relative-expression-ranked_500 | VEGFC DOCK4 HSPG2 PLXDC1 ADGRL4 TFPI STAB1 TIE1 LACC1 NOTCH1 | 2.19e-04 | 430 | 124 | 10 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_500 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | VLDLR MGAM ADGRB3 TFPI SLIT2 FBLN2 STC2 SLIT3 LRP1 LRP6 LTBP2 PLCL1 CPLANE1 MBNL3 | 2.40e-04 | 799 | 124 | 14 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 2.49e-04 | 437 | 124 | 10 | GSM777046_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | VEGFC HSPG2 ADGRL4 TFPI STAB1 OIT3 HMCN1 TIE1 LACC1 PLCL1 NOTCH1 | 2.51e-04 | 523 | 124 | 11 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_k3_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500 | 2.52e-04 | 357 | 124 | 9 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 2.55e-04 | 282 | 124 | 8 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_k4_500 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | VLDLR FBLN5 ADAMTS8 CUBN CFI ITGAV ADGRL4 FBN1 SLIT3 LRP2 PLCL1 AGRN NOTCH2 NOTCH3 SORL1 | 2.59e-04 | 905 | 124 | 15 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 2.63e-04 | 97 | 124 | 5 | GSM777046_100 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_500_k-means-cluster#1 | 3.06e-04 | 219 | 124 | 7 | JC_hmvEC_500_K1 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 3.43e-04 | 455 | 124 | 10 | GSM777055_500 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_500 | 3.49e-04 | 456 | 124 | 10 | gudmap_kidney_P0_JuxtaGlom_Ren1_500 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_1000 | VLDLR ZNF536 FBLN5 HECTD4 ADGRB3 SERINC2 SVEP1 SLIT2 FBN1 FBN2 HMCN1 SLIT3 CPLANE1 | 3.65e-04 | 734 | 124 | 13 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_500 | 4.38e-04 | 385 | 124 | 9 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_500 | |
| CoexpressionAtlas | ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_1000 | AKAP6 DIPK1C FBLN7 VTN CFI SSPOP TFPI CCDC148 FBN1 SCUBE2 CRYGN SLIT3 LRP2 LTBP2 PBXIP1 | 6.36e-04 | 986 | 124 | 15 | PCBC_ratio_ECTO_vs_SC_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | AKAP6 ZNF536 FBLN5 VTN CILP DCT LRP1B SVEP1 SLIT2 NCAN SLIT1 SLIT3 LRP2 PLCL1 FBN3 | 6.36e-04 | 986 | 124 | 15 | PCBC_EB_fibroblast_1000 |
| CoexpressionAtlas | geo_heart_top-relative-expression-ranked_1000 | AKAP6 DIPK1C FBLN5 VTN CILP PLXDC1 LRRC2 ITGB2 SVEP1 STAB1 KLHL30 DPF3 SLIT3 PLCL1 C6 | 6.63e-04 | 990 | 124 | 15 | PCBC_ctl_geo-heart_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_ReproVasc_Flk_top-relative-expression-ranked_500 | 6.75e-04 | 409 | 124 | 9 | gudmap_dev gonad_e11.5_F_ReproVasc_Flk_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+.Lv, CD45+ CD11c+ MHC-II + CD11b high CD103-, Liver, avg-3 | 6.99e-04 | 411 | 124 | 9 | GSM538239_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | VLDLR MGAM ADGRB3 SVEP1 TFPI SLIT2 FBLN2 FBN2 STC2 LRP1 LRP6 CPLANE1 MBNL3 | 7.28e-04 | 790 | 124 | 13 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 7.53e-04 | 122 | 124 | 5 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#1 | 8.12e-04 | 336 | 124 | 8 | ratio_EB_vs_SC_1000_K1 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 8.40e-04 | 125 | 124 | 5 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_500 | 8.57e-04 | 423 | 124 | 9 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_500 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_1000_k-means-cluster#4 | 9.30e-04 | 428 | 124 | 9 | JC_hmvEC_1000_K4 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | VEGFC DOCK4 FBLN5 ADGRB3 ADAMTS8 SVEP1 SLIT2 FBN1 HMCN1 SLIT3 MACF1 LTBP2 | 1.98e-13 | 187 | 124 | 12 | 92d468dde81125d51daf7abd4703741abe1ab91c |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | DOCK4 FBLN5 ADAMTS8 ALPK1 SVEP1 SLIT2 FBN1 SCUBE2 SLIT3 LRP1 MACF1 PZP | 4.40e-13 | 200 | 124 | 12 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | VEGFC DOCK4 FBLN5 ADGRB3 ADAMTS8 SVEP1 SLIT2 FBN1 HMCN1 SLIT3 LRP1 LTBP2 | 4.40e-13 | 200 | 124 | 12 | e8462395fee0a532d1e7ec7f1795f28c42af6541 |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | VEGFC FBLN5 ADGRB3 ADAMTS8 SVEP1 SLIT2 FBN1 HMCN1 SLIT3 MACF1 LTBP2 | 6.73e-12 | 191 | 124 | 11 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | VEGFC FBLN5 ADGRB3 ADAMTS8 SVEP1 SLIT2 FBN1 HMCN1 SLIT3 MACF1 LTBP2 | 7.12e-12 | 192 | 124 | 11 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | VEGFC DOCK4 FBLN5 ADGRB3 ADAMTS8 SVEP1 SLIT2 FBN1 HMCN1 SLIT3 MACF1 | 7.53e-12 | 193 | 124 | 11 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | VEGFC HSPG2 SERINC2 LRP1B ADGRL4 TFPI STAB1 FBLN2 HMCN1 TIE1 C6 | 7.53e-12 | 193 | 124 | 11 | 7261c1ce30c796b61c6ec58e64a051baa24732ff |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | FBLN5 CILP ADGRB3 SVEP1 TFPI SLIT2 FBLN2 FBN1 LRP1 LTBP2 NOTCH2 | 7.97e-12 | 194 | 124 | 11 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | FBLN5 ADGRB3 ADAMTS8 SVEP1 SLIT2 FBN1 HMCN1 SLIT3 LRP1 MACF1 LTBP2 | 8.43e-12 | 195 | 124 | 11 | df409f94f4e83be89f7a608058ee07ce3ce3a149 |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | FBLN5 ADGRB3 ADAMTS8 SVEP1 SLIT2 FBN1 HMCN1 SLIT3 LRP1 MACF1 LTBP2 | 8.43e-12 | 195 | 124 | 11 | 4243190ad291d56694e2155954dbaa879c9d3844 |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | FBLN5 ADGRB3 ADAMTS8 SVEP1 SLIT2 FBN1 HMCN1 SLIT3 LRP1 MACF1 LTBP2 | 8.91e-12 | 196 | 124 | 11 | 42e9828222a9663525d571633e8a454c30bfa7f8 |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | FBLN5 ADAMTS8 ALPK1 SVEP1 SLIT2 FBN1 SCUBE2 SLIT3 LRP1 MACF1 PZP | 1.11e-11 | 200 | 124 | 11 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | VEGFC FBLN5 ADGRB3 ADAMTS8 SVEP1 SLIT2 FBN1 HMCN1 SLIT3 LRP1 LTBP2 | 1.11e-11 | 200 | 124 | 11 | 34f52003988ce6329d8deeee1ab875fa77e01e9d |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1|E16.5-samps / Age Group, Lineage, Cell class and subclass | DOCK4 VLDLR FBLN5 ADAMTS8 SVEP1 SLIT2 FBN1 SCUBE2 LRP1 MACF1 | 3.37e-11 | 163 | 124 | 10 | f1ec2625b52664308968b01d8e0275e1e0751480 |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | HSPG2 HECTD4 ADGRB1 LRP1B SLIT2 SLIT3 LRP1 PLCL1 NOTCH2 NOTCH3 | 5.12e-11 | 170 | 124 | 10 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.31e-10 | 187 | 124 | 10 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.45e-10 | 189 | 124 | 10 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | VEGFC DOCK4 FBLN5 ADGRB3 ADAMTS8 SVEP1 SLIT2 HMCN1 SLIT3 MACF1 | 1.78e-10 | 193 | 124 | 10 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 |
| ToppCell | LA|World / Chamber and Cluster_Paper | 1.78e-10 | 193 | 124 | 10 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.97e-10 | 195 | 124 | 10 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | VEGFC FBLN5 ADGRB3 ADAMTS8 SVEP1 SLIT2 FBN1 HMCN1 SLIT3 LTBP2 | 1.97e-10 | 195 | 124 | 10 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-10 | 196 | 124 | 10 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-10 | 196 | 124 | 10 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.07e-10 | 196 | 124 | 10 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | FBLN5 ADGRB3 ADAMTS8 SVEP1 SLIT2 FBLN2 FBN1 HMCN1 SLIT3 LTBP2 | 2.29e-10 | 198 | 124 | 10 | 26e55b409db2a1637c95fae7c54b0abea1ef550c |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.29e-10 | 198 | 124 | 10 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.41e-10 | 199 | 124 | 10 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | (5)_Fibroblast-G|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.41e-10 | 199 | 124 | 10 | b4a737575be9f8c65771832dd8cd25328d5dae0d | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.41e-10 | 199 | 124 | 10 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | FBLN5 ADAMTS8 SVEP1 SLIT2 FBLN2 FBN1 HMCN1 SLIT3 MACF1 LTBP2 | 2.53e-10 | 200 | 124 | 10 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 2.53e-10 | 200 | 124 | 10 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.53e-10 | 200 | 124 | 10 | 3bdba9612cd7c612b76aa9abecc4a6529aabfc1c | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | FBLN5 ADGRB3 ADAMTS8 SVEP1 SLIT2 FBN1 HMCN1 SLIT3 LRP1 LTBP2 | 2.53e-10 | 200 | 124 | 10 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | FBLN5 ADGRB3 ADAMTS8 SVEP1 SLIT2 FBN1 HMCN1 SLIT3 LRP1 LTBP2 | 2.53e-10 | 200 | 124 | 10 | 311fab076f2ceb258e3970eb21e39344b894042a |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 2.53e-10 | 200 | 124 | 10 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.53e-10 | 200 | 124 | 10 | 1c10597edd532bf172ca09870a937d35e2585081 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 2.53e-10 | 200 | 124 | 10 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 2.53e-10 | 200 | 124 | 10 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.53e-10 | 200 | 124 | 10 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-09 | 184 | 124 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-09 | 184 | 124 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-09 | 184 | 124 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.61e-09 | 185 | 124 | 9 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.74e-09 | 186 | 124 | 9 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.01e-09 | 188 | 124 | 9 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-09 | 189 | 124 | 9 | 29287525120be2953b76881ba3cfc4379c265e7a | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-09 | 189 | 124 | 9 | 7150dad9a92a715487c2d8130fa01b752ea69663 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.15e-09 | 189 | 124 | 9 | d531399749409d614adca13d181830c6e3287508 | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-09 | 189 | 124 | 9 | 6e4c0effd5192fd00052abc048fdb87a74fb6554 | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.15e-09 | 189 | 124 | 9 | dc5164591dea45b420798b94dda211be03daa70c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.15e-09 | 189 | 124 | 9 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|kidney / Disease (COVID-19 only), tissue and cell type | 3.30e-09 | 190 | 124 | 9 | 1519f34d31fe0817184c5865a0bc9f0cb479b1a4 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.45e-09 | 191 | 124 | 9 | 3379d145d34f89150f7b06d1340022cfc6b4a6ce | |
| ToppCell | ASK440-Mesenchymal|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.45e-09 | 191 | 124 | 9 | f12959eebb4167e1aa03de05d7711a702c58b3c9 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.45e-09 | 191 | 124 | 9 | 4e4488380379ed29d7898bae4e24221e7c67eb9d | |
| ToppCell | ASK440-Mesenchymal-Fibroblast|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.45e-09 | 191 | 124 | 9 | 387296b5377ef6839f0812e5b3529a10b5f7d530 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.62e-09 | 192 | 124 | 9 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Vein|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.62e-09 | 192 | 124 | 9 | 52acaecd3703166f5ce3b328aff7c82bd142fee4 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Vein|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.62e-09 | 192 | 124 | 9 | 81baf1c4063469bb0c03a8602b40e387ba7b0dfb | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.62e-09 | 192 | 124 | 9 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.62e-09 | 192 | 124 | 9 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | 15-Trachea-Endothelial-Endothelial|Trachea / Age, Tissue, Lineage and Cell class | 3.78e-09 | 193 | 124 | 9 | 6ea0444fc3dc156997129387184e6418947f4b12 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-09 | 193 | 124 | 9 | ebd090d7801480b3cee45caac3d30cc991836769 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-09 | 193 | 124 | 9 | 22c58032e58730715224d7934968ce92d150b0e8 | |
| ToppCell | 15-Trachea-Endothelial|Trachea / Age, Tissue, Lineage and Cell class | 3.78e-09 | 193 | 124 | 9 | b1ebf8df2d55e2938e5a495ea68b80c4ac216dc0 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-09 | 193 | 124 | 9 | 573ad2f848bede1fe20c7b4b352a9242ec294725 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-09 | 193 | 124 | 9 | 45b5cab4dfeb0ed3b13631db5963740a792b810f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.96e-09 | 194 | 124 | 9 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.96e-09 | 194 | 124 | 9 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 3.96e-09 | 194 | 124 | 9 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.14e-09 | 195 | 124 | 9 | 3a0cad69cfc150a27a0666f612f5294c817197d7 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.14e-09 | 195 | 124 | 9 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 4.14e-09 | 195 | 124 | 9 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.14e-09 | 195 | 124 | 9 | 2b8ee7990267bb52b7e6ae03f509ffebf8908122 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 4.14e-09 | 195 | 124 | 9 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.14e-09 | 195 | 124 | 9 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.14e-09 | 195 | 124 | 9 | fc43cd295f2cc3f6e9442232e028944f011c82cc | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 4.14e-09 | 195 | 124 | 9 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+VCAM1+EC|kidney / Disease (COVID-19 only), tissue and cell type | 4.33e-09 | 196 | 124 | 9 | ac2c4a325efa8497a755cd31fb6a9d94d8e3bf42 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.33e-09 | 196 | 124 | 9 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.53e-09 | 197 | 124 | 9 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.53e-09 | 197 | 124 | 9 | ab5d3ebc73bd7cfc64381d14b92878b370205186 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.53e-09 | 197 | 124 | 9 | 3bb92dd8a94e2be3b7fe51c9a21b241215477ac7 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.53e-09 | 197 | 124 | 9 | 17344464fdcc5ba0c03959696b97c195f11e644c | |
| ToppCell | COPD-Stromal|COPD / Disease state, Lineage and Cell class | 4.53e-09 | 197 | 124 | 9 | d5390d86acaa8c39f1da893e8d2271f9ed2951d7 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.53e-09 | 197 | 124 | 9 | 13896ec65ccda0b928c91d41112dc01b480036b7 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.53e-09 | 197 | 124 | 9 | 5b8d0d7116b20d8e27541e88ec80c9f1f477e384 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.73e-09 | 198 | 124 | 9 | 0a4b19c3d5e65ecd24fc2ce80ac5276c813282c7 | |
| ToppCell | 3'-Adult-LymphNode-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.73e-09 | 198 | 124 | 9 | abac765c4f6864bdb1700bc546c3b9771edc25c3 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.73e-09 | 198 | 124 | 9 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lung / Location, Cell class and cell subclass | 4.73e-09 | 198 | 124 | 9 | 2d7842f352273b6b823c86eb548b9f4a4cddf0ae | |
| ToppCell | 3'-Adult-LymphNode-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.73e-09 | 198 | 124 | 9 | ff57addcbdd53e5d2d0c80ec76b5eab3b3a67ca2 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.73e-09 | 198 | 124 | 9 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | 3'-Adult-LymphNode-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.73e-09 | 198 | 124 | 9 | 698166b4ca173176ed563af6a1efc8c7d0a18e0b | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-Venous_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.94e-09 | 199 | 124 | 9 | 70e05d7c0c68c28754ce0e72434b205aed6287ae | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.94e-09 | 199 | 124 | 9 | 38ed3bc7daa993d9edcf3e7834597ebb06dd24f8 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 4.94e-09 | 199 | 124 | 9 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | ASK452-Mesenchymal-Fibroblast|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.94e-09 | 199 | 124 | 9 | 4d0bf2a4bd97e5a3bfe4570a201cc21bb9c4c1f6 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 4.94e-09 | 199 | 124 | 9 | c2c42ecf20d1924edc2f899c01dfa5fcf3c210b9 | |
| ToppCell | ASK452-Mesenchymal|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.94e-09 | 199 | 124 | 9 | 93e85e3731a9ece9aee3eb82c5dfdad331ee62d6 | |
| Computational | Metal / Ca ion binding. | 6.70e-06 | 133 | 81 | 8 | MODULE_324 | |
| Computational | Genes in the cancer module 58. | 1.62e-05 | 21 | 81 | 4 | MODULE_58 | |
| Computational | Complement. | 2.38e-05 | 23 | 81 | 4 | MODULE_130 | |
| Computational | DRG (dorsal root ganglia) genes. | HSPG2 MBNL1 LDLR TFPI STAB1 SLIT2 FBLN2 FBN1 LRP1 LTBP2 NOTCH3 | 1.34e-04 | 384 | 81 | 11 | MODULE_2 |
| Computational | ECM and collagens. | 2.81e-04 | 225 | 81 | 8 | MODULE_47 | |
| Computational | Genes in the cancer module 236. | 3.10e-04 | 18 | 81 | 3 | MODULE_236 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.90e-04 | 49 | 81 | 4 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_3 | |
| Computational | Adhesion molecules. | 6.63e-04 | 141 | 81 | 6 | MODULE_122 | |
| Drug | monatepil | 1.60e-10 | 29 | 123 | 7 | CID000060810 | |
| Drug | ezetimibe | LRP1B LDLR BRAP DHX9 SLC6A4 NPC1L1 LRP1 LRP2 LRP3 LRP6 SORL1 | 4.62e-10 | 147 | 123 | 11 | CID000150311 |
| Drug | probucol | 1.89e-08 | 162 | 123 | 10 | CID000004912 | |
| Drug | pitavastatin | 1.97e-07 | 114 | 123 | 8 | CID005282451 | |
| Drug | 1-piperidinocyclohexanecarbonitrile | 2.07e-07 | 25 | 123 | 5 | CID000062529 | |
| Drug | 25-hydroxycholesterol | 2.22e-07 | 160 | 123 | 9 | CID000065094 | |
| Drug | Bromocryptine mesylate [22260-51-1]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 1.17e-06 | 195 | 123 | 9 | 5665_UP | |
| Drug | pyrachlostrobin | HSPG2 FBLN5 ITGAV ITGB2 SVEP1 STAB1 FBLN2 FBN1 LRP2 PLAUR LTBP2 LTBP3 PBXIP1 NOTCH1 NOTCH2 NOTCH3 SORL1 | 1.76e-06 | 811 | 123 | 17 | ctd:C513428 |
| Drug | Epi Lovastatin | VLDLR LRP1B LDLR ADGRL4 TFPI NPC1L1 LRP1 LRP2 LRP3 LRP6 SORL1 | 2.51e-06 | 341 | 123 | 11 | CID000003962 |
| Drug | Etiocobalamin | 5.48e-06 | 177 | 123 | 8 | CID006450878 | |
| Drug | Rgd Peptide | 6.20e-06 | 239 | 123 | 9 | CID000104802 | |
| Drug | funiferine N-oxide | 6.68e-06 | 49 | 123 | 5 | CID000191631 | |
| Drug | epicholesterol | HSPG2 VLDLR LRP1B F7 LDLR ADGRL4 TFPI NPC1L1 LRP1 LRP2 LRP3 LRP6 NR1I3 SORL1 | 8.96e-06 | 636 | 123 | 14 | CID000000304 |
| Drug | Betulinic acid [472-15-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 1.20e-05 | 197 | 123 | 8 | 4181_UP | |
| Drug | Trifluridine [70-00-8]; Up 200; 13.6uM; HL60; HT_HG-U133A | 1.29e-05 | 199 | 123 | 8 | 6136_UP | |
| Drug | LMWH | VEGFC HSPG2 VTN TFPI2 ADAMTS8 F7 LDLR ADGRL4 TFPI SLIT2 FBLN2 LRP1 LRP2 AGRN | 1.43e-05 | 663 | 123 | 14 | CID000000772 |
| Drug | Russian VX | 2.14e-05 | 62 | 123 | 5 | CID000178033 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 2.17e-05 | 155 | 123 | 7 | 6817_DN | |
| Drug | Phosgene | 3.00e-05 | 163 | 123 | 7 | ctd:D010705 | |
| Drug | aminopropylsilane | 3.27e-05 | 12 | 123 | 3 | CID006337902 | |
| Drug | AC1L1J6H | 4.38e-05 | 236 | 123 | 8 | CID000004889 | |
| Drug | mangrove | 4.80e-05 | 468 | 123 | 11 | CID000000965 | |
| Drug | Astemizole [68844-77-9]; Up 200; 8.8uM; PC3; HT_HG-U133A | 6.05e-05 | 182 | 123 | 7 | 2049_UP | |
| Drug | 17-AAG; Up 200; 1uM; PC3; HT_HG-U133A | 7.67e-05 | 189 | 123 | 7 | 4450_UP | |
| Drug | Ovalbumin | 8.30e-05 | 82 | 123 | 5 | ctd:D010047 | |
| Drug | Flunisolide [3385-03-3]; Up 200; 9.2uM; PC3; HT_HG-U133A | 8.47e-05 | 192 | 123 | 7 | 4303_UP | |
| Drug | niobium carbide | 8.65e-05 | 3 | 123 | 2 | CID000159431 | |
| Drug | Cefepime hydrochloride [123171-59-5]; Up 200; 7.4uM; HL60; HT_HG-U133A | 9.33e-05 | 195 | 123 | 7 | 6159_UP | |
| Drug | Isoniazid [54-85-3]; Down 200; 29.2uM; PC3; HT_HG-U133A | 9.33e-05 | 195 | 123 | 7 | 5840_DN | |
| Drug | Guaifenesin [93-14-1]; Up 200; 20.2uM; PC3; HT_HG-U133A | 9.33e-05 | 195 | 123 | 7 | 4549_UP | |
| Drug | Fluorometholone [426-13-1]; Up 200; 10.6uM; PC3; HT_HG-U133A | 9.63e-05 | 196 | 123 | 7 | 5771_UP | |
| Drug | Tetracycline hydrochloride [64-75-5]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 9.63e-05 | 196 | 123 | 7 | 2243_UP | |
| Drug | Ethosuximide [77-67-8]; Up 200; 28.4uM; MCF7; HT_HG-U133A | 9.63e-05 | 196 | 123 | 7 | 2280_UP | |
| Drug | Liothyronine [6893-02-3]; Down 200; 6.2uM; HL60; HT_HG-U133A | 9.94e-05 | 197 | 123 | 7 | 2984_DN | |
| Drug | Isometheptene mucate; Up 200; 8.2uM; PC3; HT_HG-U133A | 9.94e-05 | 197 | 123 | 7 | 5082_UP | |
| Drug | Fenbufen [36330-85-5]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 9.94e-05 | 197 | 123 | 7 | 2308_UP | |
| Drug | Mafenide hydrochloride [138-37-4]; Up 200; 18uM; HL60; HG-U133A | 9.94e-05 | 197 | 123 | 7 | 1441_UP | |
| Drug | (+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.03e-04 | 198 | 123 | 7 | 3384_UP | |
| Drug | Altretamine [654-05-6]; Up 200; 19uM; MCF7; HT_HG-U133A | 1.03e-04 | 198 | 123 | 7 | 6467_UP | |
| Drug | Gabazine [105538-73-6]; Down 200; 10.8uM; HL60; HT_HG-U133A | 1.03e-04 | 198 | 123 | 7 | 1316_DN | |
| Drug | Canrenoic acid potassium salt [2181-04-6]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.03e-04 | 198 | 123 | 7 | 2228_UP | |
| Drug | Dipyrone [5907-38-0]; Up 200; 12uM; MCF7; HT_HG-U133A | 1.03e-04 | 198 | 123 | 7 | 3929_UP | |
| Drug | sodium linoleate | 1.03e-04 | 342 | 123 | 9 | CID000003931 | |
| Drug | Norcyclobenzaprine [303-50-4]; Up 200; 15.4uM; HL60; HT_HG-U133A | 1.06e-04 | 199 | 123 | 7 | 2469_UP | |
| Drug | butein; Up 200; 10uM; PC3; HG-U133A | 1.06e-04 | 199 | 123 | 7 | 582_UP | |
| Drug | Glycocholic acid [475-31-0]; Up 200; 8.6uM; HL60; HT_HG-U133A | 1.06e-04 | 199 | 123 | 7 | 2454_UP | |
| Drug | Hesperidin [520-26-3]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 1.09e-04 | 200 | 123 | 7 | 2648_UP | |
| Drug | prolate | 1.11e-04 | 46 | 123 | 4 | CID000012901 | |
| Drug | 1oz0 | 1.42e-04 | 49 | 123 | 4 | CID006323417 | |
| Disease | connective tissue disease (implicated_via_orthology) | 6.56e-08 | 3 | 120 | 3 | DOID:65 (implicated_via_orthology) | |
| Disease | Complement deficiency disease | 2.22e-07 | 33 | 120 | 5 | C0272242 | |
| Disease | Age-related macular degeneration | 7.62e-07 | 18 | 120 | 4 | cv:C0242383 | |
| Disease | adenocarcinoma (implicated_via_orthology) | 2.27e-06 | 7 | 120 | 3 | DOID:299 (implicated_via_orthology) | |
| Disease | cholesteryl ester 16:2 measurement | 2.27e-06 | 7 | 120 | 3 | EFO_0021435 | |
| Disease | central nervous system cancer (implicated_via_orthology) | 2.27e-06 | 7 | 120 | 3 | DOID:3620 (implicated_via_orthology) | |
| Disease | bipolar II disorder | 3.62e-06 | 8 | 120 | 3 | EFO_0009964 | |
| Disease | Age related macular degeneration | 6.57e-06 | 30 | 120 | 4 | C0242383 | |
| Disease | WNT1-inducible-signaling pathway protein 1 measurement | 7.71e-06 | 10 | 120 | 3 | EFO_0008321 | |
| Disease | response to docetaxel trihydrate | 1.64e-05 | 2 | 120 | 2 | GO_1902519 | |
| Disease | hyperglycemia (is_marker_for) | 1.82e-05 | 13 | 120 | 3 | DOID:4195 (is_marker_for) | |
| Disease | atrial fibrillation | 2.19e-05 | 371 | 120 | 9 | EFO_0000275 | |
| Disease | Malignant neoplasm of breast | AKAP6 VEGFC CEP85L TFPI2 NSD2 CUBN MAMDC4 BRCA2 STC2 MACF1 NOTCH1 NOTCH2 NOTCH3 PADI3 SORL1 | 3.15e-05 | 1074 | 120 | 15 | C0006142 |
| Disease | Antibody Deficiency Syndrome | 4.28e-05 | 17 | 120 | 3 | C0003257 | |
| Disease | birth weight, pelvic organ prolapse | 4.78e-05 | 49 | 120 | 4 | EFO_0004344, EFO_0004710 | |
| Disease | Sotos syndrome 1 (implicated_via_orthology) | 4.91e-05 | 3 | 120 | 2 | DOID:0112103 (implicated_via_orthology) | |
| Disease | disease of cellular proliferation (is_marker_for) | 4.91e-05 | 3 | 120 | 2 | DOID:14566 (is_marker_for) | |
| Disease | Neisseriaceae Infections | 4.91e-05 | 3 | 120 | 2 | C0085396 | |
| Disease | Pachymeningitis | 4.91e-05 | 3 | 120 | 2 | C0030167 | |
| Disease | Weill-Marchesani syndrome | 4.91e-05 | 3 | 120 | 2 | C0265313 | |
| Disease | myotonic disease (implicated_via_orthology) | 4.91e-05 | 3 | 120 | 2 | DOID:450 (implicated_via_orthology) | |
| Disease | Weill-Marchesani Syndrome, Autosomal Dominant | 4.91e-05 | 3 | 120 | 2 | C1869115 | |
| Disease | Weill-Marchesani Syndrome, Autosomal Recessive | 4.91e-05 | 3 | 120 | 2 | C1869114 | |
| Disease | Meningitis | 4.91e-05 | 3 | 120 | 2 | C0025289 | |
| Disease | bipolar disorder, sex interaction measurement | 5.12e-05 | 18 | 120 | 3 | EFO_0008343, MONDO_0004985 | |
| Disease | body weight | AKAP6 MGAM MBNL1 HECTD4 ADGRB3 LRP1B BRAP SLIT2 EYS FBN2 SLIT1 SLIT3 LTBP2 LTBP3 PLCL1 LDLRAD4 | 5.33e-05 | 1261 | 120 | 16 | EFO_0004338 |
| Disease | response to methotrexate, neurotoxicity | 6.06e-05 | 19 | 120 | 3 | EFO_0011057, GO_0031427 | |
| Disease | urinary albumin to creatinine ratio | 9.45e-05 | 179 | 120 | 6 | EFO_0007778 | |
| Disease | scoliosis (is_implicated_in) | 9.79e-05 | 4 | 120 | 2 | DOID:0060249 (is_implicated_in) | |
| Disease | Weill-Marchesani syndrome | 9.79e-05 | 4 | 120 | 2 | cv:C0265313 | |
| Disease | Weill-Marchesani syndrome (is_implicated_in) | 9.79e-05 | 4 | 120 | 2 | DOID:0050475 (is_implicated_in) | |
| Disease | Flushing | 9.79e-05 | 4 | 120 | 2 | HP_0031284 | |
| Disease | septin-10 measurement | 9.79e-05 | 4 | 120 | 2 | EFO_0802053 | |
| Disease | corneal resistance factor | 9.84e-05 | 451 | 120 | 9 | EFO_0010067 | |
| Disease | Hallux valgus | 1.06e-04 | 60 | 120 | 4 | HP_0001822 | |
| Disease | Immunologic Deficiency Syndromes | 1.09e-04 | 23 | 120 | 3 | C0021051 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipid measurement | 1.34e-04 | 120 | 120 | 5 | EFO_0004611, EFO_0004639 | |
| Disease | pallidum volume change measurement, age at assessment | 1.41e-04 | 25 | 120 | 3 | EFO_0008007, EFO_0021494 | |
| Disease | Heart valve disease | 1.59e-04 | 26 | 120 | 3 | C0018824 | |
| Disease | brain cancer (implicated_via_orthology) | 1.59e-04 | 26 | 120 | 3 | DOID:1319 (implicated_via_orthology) | |
| Disease | Geleophysic dysplasia | 1.63e-04 | 5 | 120 | 2 | C3489726 | |
| Disease | catenin alpha-2 measurement | 1.63e-04 | 5 | 120 | 2 | EFO_0802374 | |
| Disease | Acromicric Dysplasia | 1.63e-04 | 5 | 120 | 2 | C0265287 | |
| Disease | arecaidine measurement | 1.63e-04 | 5 | 120 | 2 | EFO_0801112 | |
| Disease | myotonic dystrophy type 2 (implicated_via_orthology) | 1.63e-04 | 5 | 120 | 2 | DOID:0050759 (implicated_via_orthology) | |
| Disease | pulse pressure measurement | FBLN5 MBNL1 ADAMTS8 SSPOP ARID5A SVEP1 FBN1 FBN2 MALRD1 DPF3 SLIT1 SLIT3 LRP1 LTBP2 LTBP3 NOTCH3 | 1.68e-04 | 1392 | 120 | 16 | EFO_0005763 |
| Disease | Juvenile-Onset Still Disease | 2.33e-04 | 135 | 120 | 5 | C0087031 | |
| Disease | intraocular pressure measurement | 2.43e-04 | 509 | 120 | 9 | EFO_0004695 | |
| Disease | NKG2-E type II integral membrane protein measurement | 2.43e-04 | 6 | 120 | 2 | EFO_0801842 | |
| Disease | Cannabis use | 2.43e-04 | 6 | 120 | 2 | C3160814 | |
| Disease | myotonic dystrophy type 1 (implicated_via_orthology) | 2.43e-04 | 6 | 120 | 2 | DOID:11722 (implicated_via_orthology) | |
| Disease | semenogelin-1 measurement | 2.43e-04 | 6 | 120 | 2 | EFO_0802051 | |
| Disease | colorectal cancer (implicated_via_orthology) | 2.46e-04 | 30 | 120 | 3 | DOID:9256 (implicated_via_orthology) | |
| Disease | lymphocyte count | CCHCR1 KCTD9 PLXDC1 SPTA1 MBNL1 HECTD4 NSD1 ITGB2 ADGRL4 SLC6A4 FBN1 PLAUR LTBP2 LTBP3 DMBT1 NOTCH2 | 2.95e-04 | 1464 | 120 | 16 | EFO_0004587 |
| Disease | intestinal cancer (implicated_via_orthology) | 2.98e-04 | 32 | 120 | 3 | DOID:10155 (implicated_via_orthology) | |
| Disease | body surface area | 3.05e-04 | 643 | 120 | 10 | EFO_0022196 | |
| Disease | myocardial infarction (is_marker_for) | 3.27e-04 | 33 | 120 | 3 | DOID:5844 (is_marker_for) | |
| Disease | low density lipoprotein cholesterol measurement, C-reactive protein measurement | 3.90e-04 | 35 | 120 | 3 | EFO_0004458, EFO_0004611 | |
| Disease | COVID-19 symptoms measurement | 3.90e-04 | 35 | 120 | 3 | EFO_0600019 | |
| Disease | total cholesterol measurement, response to escitalopram, response to citalopram | 4.52e-04 | 8 | 120 | 2 | EFO_0004574, EFO_0006329, EFO_0007871 | |
| Disease | CREB-binding protein measurement | 4.52e-04 | 8 | 120 | 2 | EFO_0801502 | |
| Disease | neurexophilin-1 measurement | 4.52e-04 | 8 | 120 | 2 | EFO_0008244 | |
| Disease | free cholesterol change measurement, high density lipoprotein cholesterol measurement | 4.52e-04 | 8 | 120 | 2 | EFO_0004612, EFO_0020905 | |
| Disease | diastolic blood pressure, self reported educational attainment | 4.52e-04 | 8 | 120 | 2 | EFO_0004784, EFO_0006336 | |
| Disease | sulfatase-modifying factor 1 measurement | 4.52e-04 | 8 | 120 | 2 | EFO_0802098 | |
| Disease | Paroxysmal atrial fibrillation | 4.53e-04 | 156 | 120 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 4.53e-04 | 156 | 120 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 4.53e-04 | 156 | 120 | 5 | C2585653 | |
| Disease | FEV/FEC ratio | AKAP6 VEGFC HSPG2 MGAM NSD1 ITGAV FBN1 HMCN1 LRP1 LTBP2 LTBP3 PLCL1 DMBT1 SORL1 | 4.77e-04 | 1228 | 120 | 14 | EFO_0004713 |
| Disease | blood molybdenum measurement | 4.99e-04 | 38 | 120 | 3 | EFO_0007582 | |
| Disease | Atrial Fibrillation | 5.08e-04 | 160 | 120 | 5 | C0004238 | |
| Disease | melanoma | 5.45e-04 | 248 | 120 | 6 | C0025202 | |
| Disease | apolipoprotein D measurement | 5.80e-04 | 9 | 120 | 2 | EFO_0020156 | |
| Disease | cortical thickness | AKAP6 HSPG2 FBLN7 ZNF536 ADAMTS8 STAB1 SLIT2 FBN1 FBN2 MALRD1 LRP1 ADAMTS20 MACF1 | 6.12e-04 | 1113 | 120 | 13 | EFO_0004840 |
| Disease | Squamous cell carcinoma of esophagus | 6.23e-04 | 95 | 120 | 4 | C0279626 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 6.25e-04 | 41 | 120 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 6.25e-04 | 41 | 120 | 3 | C0858252 | |
| Disease | Tumoral calcinosis | 6.71e-04 | 42 | 120 | 3 | C0263628 | |
| Disease | Calcinosis | 6.71e-04 | 42 | 120 | 3 | C0006663 | |
| Disease | Microcalcification | 6.71e-04 | 42 | 120 | 3 | C0521174 | |
| Disease | mean arterial pressure, alcohol drinking | 7.00e-04 | 98 | 120 | 4 | EFO_0004329, EFO_0006340 | |
| Disease | apolipoprotein A 1 measurement | MGAM VTN RNF185 MBNL1 NSD1 HNRNPUL1 LDLR STAB1 LRP1 MACF1 SORL1 | 7.00e-04 | 848 | 120 | 11 | EFO_0004614 |
| Disease | spleen volume | 7.19e-04 | 43 | 120 | 3 | EFO_0600047 | |
| Disease | aortic aneurysm | 7.23e-04 | 10 | 120 | 2 | EFO_0001666 | |
| Disease | Atypical Hemolytic Uremic Syndrome | 7.23e-04 | 10 | 120 | 2 | C2931788 | |
| Disease | leptin measurement, sex interaction measurement | 7.23e-04 | 10 | 120 | 2 | EFO_0005000, EFO_0008343 | |
| Disease | pancreatic adenocarcinoma (is_marker_for) | 7.23e-04 | 10 | 120 | 2 | DOID:4074 (is_marker_for) | |
| Disease | allergic rhinitis (biomarker_via_orthology) | 7.23e-04 | 10 | 120 | 2 | DOID:4481 (biomarker_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 7.56e-04 | 264 | 120 | 6 | EFO_0008317, EFO_0020944 | |
| Disease | cancer (implicated_via_orthology) | 8.17e-04 | 268 | 120 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | hematocrit | VEGFC VLDLR MBNL1 HECTD4 SERINC2 BRAP ADGRL4 STAB1 TIE1 DPF3 LRP2 DMBT1 | 8.69e-04 | 1011 | 120 | 12 | EFO_0004348 |
| Disease | tumor necrosis factor receptor superfamily member 11B measurement | 8.81e-04 | 11 | 120 | 2 | EFO_0020801 | |
| Disease | pulmonary fibrosis | 8.81e-04 | 11 | 120 | 2 | EFO_0009448 | |
| Disease | forced expiratory volume, body mass index | 8.81e-04 | 11 | 120 | 2 | EFO_0004314, EFO_0004340 | |
| Disease | Marfan Syndrome | 8.81e-04 | 11 | 120 | 2 | C0024796 | |
| Disease | hemolysis | 9.33e-04 | 47 | 120 | 3 | EFO_0009473 | |
| Disease | congenital diaphragmatic hernia (implicated_via_orthology) | 1.05e-03 | 12 | 120 | 2 | DOID:3827 (implicated_via_orthology) | |
| Disease | Mitral valve prolapse, response to surgery | 1.05e-03 | 12 | 120 | 2 | EFO_0009951, HP_0001634 | |
| Disease | stenosing tenosynovitis | 1.05e-03 | 12 | 120 | 2 | EFO_0010822 | |
| Disease | complement component C7 measurement | 1.05e-03 | 12 | 120 | 2 | EFO_0008093 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NGVTICEDDNECGNL | 51 | Q9HBW9 | |
| QLCDGEDNCGDLSDE | 246 | Q6UXC1 | |
| DFEEQCAGGEDEQAC | 476 | Q6UXC1 | |
| CNGRQFNSIEDDVCQ | 221 | Q7Z569 | |
| EALQCQEEGCRHGAE | 271 | Q03989 | |
| YQCNGEVDCITGEDE | 276 | P05156 | |
| NEENIGNECLCDLTN | 96 | Q8NFR7 | |
| GNECLCDLTNFEQEL | 101 | Q8NFR7 | |
| RHLVCNGDQDCLDGS | 111 | P07357 | |
| GVLEEGRQCNREACG | 301 | O14514 | |
| QCEGTGEEVRRCNEQ | 491 | O60242 | |
| NGVVEREEQCDCGSV | 411 | Q9UKJ8 | |
| LLTRQNFCGQEGLCD | 316 | Q9UP79 | |
| GILESNEECDCGNKN | 396 | Q9Y3Q7 | |
| CVLENCEFVGSENNS | 241 | Q9UK96 | |
| SGEDGDCEQELCRQR | 676 | O00468 | |
| NGRLEGNEICDCGTE | 396 | Q8TC27 | |
| NCLCVNGEIEGLNDT | 26 | Q9BTT0 | |
| ENVQGCRCQERFEAG | 346 | P78325 | |
| CACAGGFALDAQERN | 1011 | Q75N90 | |
| LDRGGGNCTDINECA | 1436 | Q75N90 | |
| FDQALGGCQEVDECA | 2601 | Q75N90 | |
| NGSRREDCECDNGHL | 1781 | P59510 | |
| VCEVFESDCGNNKNE | 466 | Q96QP1 | |
| RVCGLCGNFDDNAIN | 1021 | Q9HC84 | |
| EVCEEFSQQLNSNGC | 281 | P20742 | |
| EREDECFSCGDAGQL | 2116 | Q96L73 | |
| NNVVGRLCNECADGS | 896 | P98160 | |
| DAANCLGICEFGEQQ | 131 | Q0D2K2 | |
| DELRNCVVCGDQATG | 6 | Q14994 | |
| VCQDVNECELYGQEG | 221 | Q53RD9 | |
| GFTGVLCEENIDNCD | 561 | Q04721 | |
| GTSGVNCEINFDDCA | 636 | Q04721 | |
| ENCDLSGCDLQEANL | 351 | Q7L273 | |
| CQNDATCLDQIGEFQ | 461 | P46531 | |
| RVCACADNQLLDENG | 816 | Q9NZR2 | |
| DNKDDCGDGSDERNC | 2911 | Q9NZR2 | |
| GSDEENCERGGNICR | 3661 | Q9NZR2 | |
| NCERGGNICRADEFL | 3666 | Q9NZR2 | |
| NNGTCISDNENLFCE | 2346 | Q5T1H1 | |
| ENDDQLLFCDDCDRG | 326 | Q92784 | |
| RELFNFSSCQGQEDC | 321 | Q5MY95 | |
| SDEGELCDQCSLNNG | 1176 | Q07954 | |
| AQDEFECANGECINF | 2526 | Q07954 | |
| FRCNGQDNCGDGEDE | 3431 | Q07954 | |
| ENGDSAENCTARGCI | 1866 | O43451 | |
| VCNNEAESIHCDGEG | 331 | Q9NYF5 | |
| QRDAFGRGCIDVNEC | 891 | P98095 | |
| FDENECEQNNGGCSE | 181 | Q8WWZ8 | |
| RQSEDECFRCGDGGQ | 1236 | O96028 | |
| GACDQDVDECSIGAN | 386 | Q9UM47 | |
| LEQLCQAGGQCVDED | 1051 | Q9UM47 | |
| CSQTEGNGEECIERV | 636 | O94854 | |
| CCSNISYERDGEQDN | 46 | Q8IV20 | |
| LGQASCQADEFRCDN | 161 | O75074 | |
| IDGALRCNGDANCQD | 1301 | O75581 | |
| LGDCENLERLDCSGN | 186 | Q9BYS8 | |
| GVDDCRDNSDEQGCE | 3701 | P98164 | |
| GQNDCGDNSDEENCA | 3741 | P98164 | |
| DRTSCLDINECEQFG | 4001 | P98164 | |
| RVCGLCGNFDDIAVN | 1031 | P98088 | |
| CDLNCEGRQDRNFVD | 121 | Q9ULW8 | |
| RATECCGNQAAGNDA | 1366 | Q9Y4D8 | |
| EGCNFTGQCLEFLED | 101 | Q8WXF5 | |
| GRKCEGSDVQSDFCN | 4736 | Q96RW7 | |
| LNEGVARCNESQGDD | 236 | Q9UHC9 | |
| CECQTQGRSSQELEG | 481 | P05107 | |
| SCNFVDNCGDNTDEN | 1501 | Q5VYJ5 | |
| YICEDINECEINNGG | 301 | O60494 | |
| EECLRQNEAAVGNCA | 66 | Q9BSY4 | |
| LATGGQNEEEFRCCI | 721 | Q8N1I0 | |
| ADSLSCLQEGQCEND | 706 | P51587 | |
| LECNGENDCGDNSDE | 156 | P13671 | |
| ENDCGDNSDERDCGR | 161 | P13671 | |
| QESNLRGCGDVEDSN | 2096 | Q9H799 | |
| FTSTGQCNDRNECQE | 1841 | P35555 | |
| NDCIDVDECASGNGN | 1926 | P35555 | |
| AIGGRCKNQCDDSEF | 56 | Q30KQ8 | |
| PCRSQDIDADGQGFC | 171 | P06756 | |
| DNCGQGGTVCREESR | 166 | Q5SZL2 | |
| EEAVCQGDNLDRCSS | 761 | Q8TD31 | |
| FQLANGTVCEDVNEC | 1166 | Q14767 | |
| NTDGSFRCLCDQGFE | 1321 | Q14767 | |
| SQGGGACRDVNECAE | 736 | Q9NS15 | |
| REYQRGNCNRGENDC | 186 | Q9NR56 | |
| REFQRGNCTRGENDC | 181 | Q9NUK0 | |
| VDAGAGLTDCQQFEC | 226 | Q96T53 | |
| GQCQDDQGFALNFTC | 146 | Q6UY11 | |
| QCTNGFDLDRQSGQC | 26 | Q9UBX5 | |
| DECAENINLCENGQC | 1451 | P35556 | |
| IDECSNGDNLCQRNA | 1851 | P35556 | |
| DTNDANVVCRQLGCG | 1281 | Q9UGM3 | |
| GRQCEDIDECGNELN | 81 | Q9NQ36 | |
| CLDVDECLENNGGCQ | 126 | Q9NQ36 | |
| RRLLCNGDNDCGDQS | 136 | P07358 | |
| NGDNDCGDQSDEANC | 141 | P07358 | |
| RLRCNGDNDCGDFSD | 116 | P02748 | |
| LEQNCTGDEDCNFFD | 311 | Q0P6D2 | |
| GEDDDANCNLICGDE | 601 | Q08211 | |
| NDVIGCFADFECGND | 326 | Q9BUJ2 | |
| EDEVDNRTDNGSNCG | 976 | Q5JY77 | |
| CDGIIQCRDGSDEDA | 1296 | Q92673 | |
| CDGHQDCQDGRDEAN | 1491 | Q92673 | |
| EQAQVCDGREDCLDG | 2406 | A2VEC9 | |
| DDQLICVNENGGCEQ | 146 | P08709 | |
| QGFAGENCEIDIDDC | 1036 | O14594 | |
| CLNNAVCEDQVGGFL | 1316 | Q4LDE5 | |
| AGCCLALEQNGTEEN | 2016 | Q13023 | |
| TCAGQQDNGIRCRDA | 436 | O75339 | |
| LGFEGQRCEINPDDC | 986 | O75094 | |
| RNNGLADQICEDCAF | 176 | Q15111 | |
| NGDCRVEECALGQDL | 31 | Q03405 | |
| SQCGANREFDENTCQ | 326 | P49767 | |
| DEFGNRFDVNNCSIC | 66 | P60852 | |
| QGCSGVDECARQEGL | 586 | Q96AQ6 | |
| QRCDGVNDCFDESDE | 501 | Q7RTY8 | |
| FRDCENGRDEQNCTQ | 541 | Q7RTY8 | |
| ELLQEARCQGDCAGA | 296 | Q8N271 | |
| EQACREGRFGQSCQE | 256 | P35590 | |
| GVFECFENNSCEIRG | 66 | O76061 | |
| HCNGVDDCGNQADED | 46 | Q9HBX9 | |
| DRNGTCVCQENFRGS | 131 | Q9NY15 | |
| CADGFEGENCEVNVD | 986 | O94813 | |
| ARGCGYQLCINEQEE | 441 | A6NDV4 | |
| LGNSLIECSACDGNE | 1561 | P02549 | |
| GGQDSTFECNICLDT | 31 | Q96GF1 | |
| NFATGRNECDVCTDQ | 246 | P40126 | |
| RNECDVCTDQLFGAA | 251 | P40126 | |
| INCCDDGEGSQQEVI | 1221 | Q86X10 | |
| GCEGNQNRFESLEEC | 86 | P10646 | |
| ENESERNCLEESEGC | 351 | Q9BVS4 | |
| SGEEFFNNCEVLQCG | 446 | Q6IQ21 | |
| GGGEQSANEFRCEVC | 336 | O15090 | |
| CEECGQGFNQSSRLQ | 561 | Q9NYT6 | |
| CGGNDNNFVSREDCK | 191 | P48307 | |
| GCAQEAEGRMCEDFQ | 346 | Q8IUK5 | |
| CGGNEFERCSSQDSI | 46 | Q6ZN57 | |
| QLSACEDGEDCQENG | 11 | P31645 | |
| CEGTECQNGANCVDQ | 1131 | O75093 | |
| QESCKGRCTEGFNVD | 21 | P04004 | |
| NGRELCDCEQCGEVF | 141 | Q9BUY5 | |
| ACEGRAFDNEQDGVT | 371 | Q96SA4 | |
| SSCCEEEQTQGRGAE | 281 | Q9UJK0 | |
| QCNGIRDCVDGSDEV | 296 | P98155 | |
| TAVGDRCERNEFQCQ | 21 | P01130 | |
| NDCGDNSDEENCLLV | 36 | O15165 |